Retinoblastoma	O
protein	O
expression	O
leads	O
to	O
reduced	O
Oct-1	B-protein
DNA	O
binding	O
activity	O
and	O
enhances	O
interleukin-8	B-protein
expression	O
.	O

Tumor	O
cell	O
lines	O
with	O
a	O
defective	O
retinoblastoma	B-DNA
gene	I-DNA
are	O
unable	O
to	O
transcribe	O
the	O
HLA	B-DNA
class	I-DNA
II	I-DNA
genes	I-DNA
in	O
response	O
to	O
IFN-gamma	B-protein
treatment	O
,	O
and	O
reconstitution	O
of	O
functional	O
Rb	B-protein
rescues	O
IFN-gamma-induced	O
class	B-DNA
II	I-DNA
gene	I-DNA
expression	O
.	O

However	O
,	O
the	O
molecular	O
mechanism	O
of	O
Rb	B-protein
rescue	O
of	O
the	O
class	B-DNA
II	I-DNA
genes	I-DNA
is	O
unknown	O
.	O

We	O
have	O
examined	O
the	O
effect	O
of	O
Rb	B-protein
expression	O
on	O
the	O
activation	O
of	O
the	O
promoter	O
for	O
HLA-DRA	B-DNA
,	O
the	O
prototype	B-DNA
class	I-DNA
II	I-DNA
gene	I-DNA
.	O

Oct-1	B-protein
,	O
a	O
POU	B-protein
domain	I-protein
transcription	I-protein
factor	I-protein
,	O
was	O
identified	O
as	O
a	O
repressor	O
of	O
HLA-DRA	B-DNA
promoter	O
activity	O
in	O
the	O
Rb-defective	B-cell_type
cells	I-cell_type
.	O

Rb	B-protein
expression	O
led	O
to	O
phosphorylation	O
of	O
Oct-1	B-protein
,	O
thus	O
relieving	O
its	O
repressive	O
effect	O
.	O

Oct-1	B-protein
has	O
also	O
been	O
shown	O
to	O
repress	O
interleukin	B-protein
8	I-protein
promoter	O
activity	O
.	O

Consistent	O
with	O
reduced	O
levels	O
of	O
Oct-1	B-protein
DNA	O
binding	O
activity	O
in	O
the	O
Rb-transformed	B-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
interleukin	B-protein
8	I-protein
expression	O
is	O
higher	O
in	O
these	O
cell	O
lines	O
.	O

Vol	NULL
.	NULL

10	NULL
,	NULL
457-465	NULL
,	NULL
July	NULL
1999	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Retinoblastoma	NULL
Protein	NULL
Expression	NULL
Leads	NULL
to	NULL
Reduced	NULL
Oct-1	NULL
DNA	NULL
Binding	NULL
Activity	NULL
and	NULL
Enhances	NULL
Interleukin-8	NULL
Expression	NULL
'	NULL
Hongquan	NULL
Zhang	NULL
,	NULL
Alexander	NULL
T.	NULL
Shepherd	NULL
,	NULL
Donna	NULL
D.	NULL
Eason	NULL
,	NULL
Sheng	NULL
Wei	NULL
,	NULL
Jose	NULL
I.	NULL
Diaz	NULL
,	NULL
Julie	NULL
Y.	NULL
Djeu	NULL
,	NULL
Gary	NULL
D.	NULL
Wu	NULL
,	NULL
and	NULL
George	NULL
Blanck	NULL
``	NULL
Departments	NULL
of	NULL
Pathology	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
[	NULL
H.	NULL
Z.	NULL
,	NULL
J.	NULL
I.	NULL
D.	NULL
]	NULL
and	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
[	NULL
A.	NULL
T.	NULL
S.	NULL
,	NULL
D.	NULL
D.	NULL
E.	NULL
,	NULL
G	NULL
.	NULL

B	NULL
.	NULL
]	NULL

,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
Immunology	NULL
Program	NULL
[	NULL
S.	NULL
W.	NULL
,	NULL
J.	NULL
Y.	NULL
D.	NULL
,	NULL
G	NULL
.	NULL

B	NULL
.	NULL
]	NULL

,	NULL
H.	NULL
Lee	NULL
Moffitt	NULL
Cancer	NULL
Center	NULL
and	NULL
Research	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
South	NULL
Florida	NULL
,	NULL
Tampa	NULL
,	NULL
Florida	NULL
33612	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pennsylvania	NULL
19104	NULL
[	NULL
G.	NULL
D.	NULL
W.	NULL
]	NULL
Abstract	NULL
Tumor	NULL
cell	NULL
lines	NULL
with	NULL
a	NULL
defective	NULL
retinoblastoma	NULL
gene	NULL
are	NULL
unable	NULL
to	NULL
transcribe	NULL
the	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
treatment	NULL
,	NULL
and	NULL
reconstitution	NULL
of	NULL
functional	NULL
Rb	NULL
rescues	NULL
IFN-y-induced	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
Rb	NULL
rescue	NULL
of	NULL
the	NULL
class	NULL
II	NULL
genes	NULL
is	NULL
unknown	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Rb	NULL
expression	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
HLA-DRA	NULL
,	NULL
the	NULL
prototype	NULL
class	NULL
II	NULL
gene	NULL
.	NULL

Oct-1	NULL
,	NULL
a	NULL
POU	NULL
domain	NULL
transcription	NULL
factor	NULL
,	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
Rb-defective	NULL
cells	NULL
.	NULL

Rb	NULL
expression	NULL
led	NULL
to	NULL
phosphorylation	NULL
of	NULL
Oct-1	NULL
,	NULL
thus	NULL
relieving	NULL
its	NULL
repressive	NULL
effect	NULL
.	NULL

Oct-1	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
repress	NULL
interleukin	NULL
8	NULL
promoter	NULL
activity	NULL
.	NULL

Consistent	NULL
with	NULL
reduced	NULL
levels	NULL
of	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
Rb-transformed	NULL
cell	NULL
lines	NULL
,	NULL
interleukin	NULL
8	NULL
expression	NULL
is	NULL
higher	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

Introduction	NULL
Rb°	NULL
,	NULL
a	NULL
well-studied	NULL
tumor	NULL
suppressor	NULL
,	NULL
is	NULL
required	NULL
for	NULL
regulating	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Inactivation	NULL
of	NULL
the	NULL
Rb	NULL
gene	NULL
due	NULL
to	NULL
deletions	NULL
or	NULL
mutations	NULL
has	NULL
been	NULL
found	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
tumors	NULL
,	NULL
including	NULL
retinoblastoma	NULL
,	NULL
os-teosarcoma	NULL
,	NULL
and	NULL
lung	NULL
,	NULL
bladder	NULL
,	NULL
and	NULL
prostate	NULL
carcinomas	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Reconstituting	NULL
functional	NULL
Rb	NULL
in	NULL
some	NULL
of	NULL
these	NULL
tumor	NULL
cell	NULL
lines	NULL
leads	NULL
to	NULL
potentially	NULL
contradictory	NULL
results	NULL
.	NULL

The	NULL
retinoblastoma	NULL
cell	NULL
line	NULL
Weri-27	NULL
and	NULL
the	NULL
osteosarcoma	NULL
cell	NULL
line	NULL
Saos-2	NULL
have	NULL
significantly	NULL
reduced	NULL
tumor	NULL
formation	NULL
capacities	NULL
after	NULL
transient	NULL
transfection	NULL
of	NULL
an	NULL
Rb	NULL
expression	NULL
vector	NULL
and	NULL
injection	NULL
Received	NULL
4/2/99	NULL
;	NULL
revised	NULL
5/14/99	NULL
;	NULL
accepted	NULL
5/18/99	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

!	NULL

Supported	NULL
by	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
RPG-98-184-01-CIM	NULL
,	NULL
American	NULL
Heart	NULL
Association	NULL
of	NULL
Florida	NULL
Grant	NULL
9601461	NULL
,	NULL
an	NULL
American	NULL
Lung	NULL
Association	NULL
of	NULL
Florida	NULL
grant	NULL
(	NULL
to	NULL
G	NULL
.	NULL

B	NULL
.	NULL
)	NULL

;	NULL
and	NULL
NIH	NULL
Grant	NULL
AI39368	NULL
(	NULL
to	NULL
G.	NULL
D.	NULL
W.	NULL
)	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
12901	NULL
Bruce	NULL
B.	NULL
Downs	NULL
Boulevard	NULL
MDC	NULL
7	NULL
,	NULL
Tampa	NULL
,	NULL
FL	NULL
33612	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
813	NULL
)	NULL
974-9585	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
813	NULL
)	NULL
974-7280	NULL
;	NULL
E-mail	NULL
:	NULL
gblanck	NULL
@	NULL
com1.med.usf.edu	NULL
.	NULL

°	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Rb	NULL
,	NULL
retinoblastoma	NULL
protein	NULL
;	NULL
IFN-y	NULL
,	NULL
interfer-on-y	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
H2B	NULL
,	NULL
histone	NULL
2B	NULL
;	NULL
snRNA	NULL
,	NULL
small	NULL
nuclear	NULL
RNA	NULL
.	NULL

into	NULL
nude	NULL
mice	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Tumorigenicity	NULL
is	NULL
also	NULL
partially	NULL
suppressed	NULL
by	NULL
stable	NULL
expression	NULL
of	NULL
Rb	NULL
in	NULL
the	NULL
Rb-defective	NULL
bladder	NULL
carcinoma	NULL
cell	NULL
line	NULL
5637	NULL
,	NULL
the	NULL
Weri-27	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
the	NULL
Saos-2	NULL
cell	NULL
line	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
some	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
Rb	NULL
expression	NULL
in	NULL
the	NULL
Rb-defective	NULL
tumor	NULL
cell	NULL
lines	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
growth	NULL
rate	NULL
or	NULL
morphology	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
cultured	NULL
tumor	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Discrepancies	NULL
between	NULL
the	NULL
growth	NULL
characteristics	NULL
of	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
effectiveness	NULL
of	NULL
Rb	NULL
expression	NULL
in	NULL
eliminating	NULL
tumor	NULL
growth	NULL
in	NULL
vivo	NULL
may	NULL
reflect	NULL
a	NULL
host	NULL
's	NULL
defense	NULL
mechanism	NULL
cooperating	NULL
with	NULL
Rb	NULL
in	NULL
the	NULL
prevention	NULL
of	NULL
tumorigenesis	NULL
.	NULL

Whereas	NULL
an	NULL
extensive	NULL
body	NULL
of	NULL
work	NULL
on	NULL
Rb	NULL
has	NULL
focused	NULL
on	NULL
its	NULL
growth	NULL
suppression	NULL
function	NULL
,	NULL
there	NULL
is	NULL
emerging	NULL
evidence	NULL
indicating	NULL
that	NULL
Rb	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
the	NULL
immune	NULL
functions	NULL
of	NULL
tumor	NULL
cells	NULL
(	NULL
8-13	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
aberrant	NULL
production	NULL
of	NULL
IL-6	NULL
by	NULL
neoplastic	NULL
cells	NULL
is	NULL
regarded	NULL
as	NULL
a	NULL
strong	NULL
contributory	NULL
factor	NULL
in	NULL
the	NULL
growth	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
malignancies	NULL
,	NULL
especially	NULL
multiple	NULL
myeloma	NULL
,	NULL
leukemia	NULL
,	NULL
and	NULL
lymphomas	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

A	NULL
survey	NULL
of	NULL
the	NULL
Rb	NULL
status	NULL
in	NULL
the	NULL
cells	NULL
representing	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
indicated	NULL
that	NULL
Rb	NULL
defects	NULL
in	NULL
the	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
blast	NULL
cells	NULL
closely	NULL
correlate	NULL
with	NULL
the	NULL
increased	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Also	NULL
,	NULL
a	NULL
reduction	NULL
of	NULL
Rb	NULL
expression	NULL
with	NULL
antisense	NULL
oligonucleotide	NULL
in	NULL
the	NULL
normal	NULL
blast	NULL
cells	NULL
induces	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
Rb	NULL
represses	NULL
an	NULL
IL-6	NULL
promoter	NULL
reporter	NULL
construct	NULL
(	NULL
8	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
encode	NULL
heterodimeric	NULL
cell	NULL
surface	NULL
proteins	NULL
that	NULL
present	NULL
antigens	NULL
to	NULL
CD4+	NULL
T	NULL
helper	NULL
cells	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
the	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
on	NULL
tumor	NULL
cells	NULL
and	NULL
the	NULL
T-cell	NULL
receptors	NULL
may	NULL
help	NULL
the	NULL
host	NULL
's	NULL
immune	NULL
system	NULL
to	NULL
recognize	NULL
tumor	NULL
cell	NULL
antigens	NULL
and	NULL
to	NULL
mount	NULL
an	NULL
immune	NULL
response	NULL
against	NULL
tumor	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Studies	NULL
from	NULL
our	NULL
laboratory	NULL
have	NULL
established	NULL
that	NULL
Rb	NULL
is	NULL
required	NULL
for	NULL
the	NULL
IFN-y	NULL
inducibility	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

Tumor	NULL
cell	NULL
lines	NULL
defective	NULL
for	NULL
Rb	NULL
expression	NULL
express	NULL
little	NULL
or	NULL
no	NULL
HLA	NULL
class	NULL
II	NULL
after	NULL
IFN-y	NULL
treatment	NULL
;	NULL
however	NULL
,	NULL
HLA	NULL
class	NULL
II	NULL
inducibility	NULL
can	NULL
be	NULL
restored	NULL
by	NULL
exogenous	NULL
expression	NULL
of	NULL
Rb	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
used	NULL
a	NULL
combination	NULL
of	NULL
EMSAs	NULL
and	NULL
transfection	NULL
experiments	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
Rb	NULL
expression	NULL
on	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

Oct-1	NULL
,	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
POU	NULL
domain	NULL
transcription	NULL
factor	NULL
,	NULL
was	NULL
determined	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
effect	NULL
of	NULL
Rb	NULL
expression	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
heavy	NULL
chain	NULL
of	NULL
the	NULL
HLA	NULL
class	NULL
II	NULL
DR	NULL
molecule	NULL
.	NULL

This	NULL
work	NULL
also	NULL
led	NULL
to	NULL
the	NULL
conclusion	NULL
that	NULL
Rb	NULL
enhances	NULL
IL-8	NULL
expression	NULL
by	NULL
an	NULL
Oct-1-related	NULL
mechanism	NULL
.	NULL

Results	NULL
Oct-1	NULL
Binding	NULL
Activity	NULL
to	NULL
the	NULL
HLA-DRA	NULL
Promoter	NULL
Is	NULL
Reduced	NULL
in	NULL
Rb-transformed	NULL
Cell	NULL
Lines	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
mechanism	NULL
of	NULL
Rb	NULL
rescue	NULL
of	NULL
HLA-DRA	NULL
inducibility	NULL
,	NULL
we	NULL
compared	NULL
HLA-DRA	NULL
promoter	NULL
protein	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
458	NULL
-	NULL
Rb	NULL
Regulation	NULL
of	NULL
Oct-1	NULL
and	NULL
IL-8	NULL
Table	NULL
1	NULL
-	NULL
Cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
Cell	NULL
lines	NULL
(	NULL
refs	NULL
.	NULL
)	NULL

Tissue	NULL
origin	NULL
Rb	NULL
status	NULL
5637	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
1A4	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
141	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
Human	NULL
bladder	NULL
carcinoma	NULL
Negative	NULL
G418-resistant	NULL
,	NULL
5637	NULL
control	NULL
subclone	NULL
Negative	NULL
G418-resistant	NULL
,	NULL
5637	NULL
control	NULL
subclone	NULL
Negative	NULL
12-27	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
-	NULL
RB-transformed	NULL
5637	NULL
subclone	NULL
Positive	NULL
10-1	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
RB-transformed	NULL
5637	NULL
subclone	NULL
Positive	NULL
$	NULL
4	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
Human	NULL
breast	NULL
carcinoma	NULL
Negative	NULL
S4-MTRb-1	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
-	NULL
Rb-transformed	NULL
$	NULL
4	NULL
clone	NULL
Positive	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
human	NULL
tumor	NULL
cell	NULL
lines	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
Refs	NULL
.	NULL

6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
16	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
5637	NULL
cells	NULL
and	NULL
its	NULL
subclones	NULL
,	NULL
as	NULL
well	NULL
as	NULL
MDA-468-54	NULL
(	NULL
S4	NULL
)	NULL
and	NULL
its	NULL
Rb-transformed	NULL
subclone	NULL
S4-MTRb-1	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
these	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
,	NULL
and	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
in	NULL
the	NULL
experiment	NULL
included	NULL
the	NULL
previously	NULL
characterized	NULL
HLA-DRA	NULL
promoter	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
octamer	NULL
box	NULL
elements	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Oct-1	NULL
binding	NULL
activity	NULL
was	NULL
markedly	NULL
reduced	NULL
in	NULL
the	NULL
Rb-transformed	NULL
subclones	NULL
compared	NULL
to	NULL
the	NULL
Rb-defective	NULL
control	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
compare	NULL
Lane	NULL
2	NULL
with	NULL
Lane	NULL
1	NULL
and	NULL
Lane	NULL
4	NULL
with	NULL
Lane	NULL
3	NULL
)	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
Y	NULL
box	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
Oct-1	NULL
was	NULL
verified	NULL
by	NULL
anti-Oct-1	NULL
antibody	NULL
supershift	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
Lanes	NULL
6-8	NULL
)	NULL
and	NULL
by	NULL
binding	NULL
competition	NULL
with	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutated	NULL
octamer	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
Lanes	NULL
9-12	NULL
)	NULL
.	NULL

Nonspecific	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
was	NULL
completely	NULL
eliminated	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
both	NULL
wild-type	NULL
and	NULL
mutated	NULL
octamer	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lower	NULL
bands	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
is	NULL
activated	NULL
by	NULL
IFN-y	NULL
treatment	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
difference	NULL
in	NULL
Oct-1	NULL
binding	NULL
in	NULL
the	NULL
Rb-defective	NULL
versus	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
is	NULL
maintained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
IFN-y-treated	NULL
and	NULL
untreated	NULL
5637	NULL
cells	NULL
and	NULL
its	NULL
subclones	NULL
,	NULL
1A¥4	NULL
and	NULL
12-27	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
result	NULL
indicated	NULL
that	NULL
IFN-y	NULL
treatment	NULL
caused	NULL
a	NULL
slight	NULL
decrease	NULL
in	NULL
the	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
Rb-defective	NULL
5637	NULL
subclone	NULL
1A4	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
Rb-transformed	NULL
subclone	NULL
12-27	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
compare	NULL
Lanes	NULL
1-3	NULL
with	NULL
Lanes	NULL
4-6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
Oct-1	NULL
binding	NULL
between	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
cells	NULL
remained	NULL
unchanged	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
.	NULL

IFN-y-treated	NULL
Rb-defective	NULL
cells	NULL
retained	NULL
a	NULL
higher	NULL
Oct-1	NULL
binding	NULL
activity	NULL
than	NULL
their	NULL
Rb-transformed	NULL
counterparts	NULL
.	NULL

The	NULL
Repressive	NULL
Effect	NULL
of	NULL
Oct-1	NULL
on	NULL
HLA-DRA	NULL
Promoter	NULL
Activity	NULL
Is	NULL
Relieved	NULL
by	NULL
Rb	NULL
Expression	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activities	NULL
could	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
devised	NULL
a	NULL
strategy	NULL
to	NULL
assess	NULL
the	NULL
impact	NULL
of	NULL
endogenous	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
on	NULL
an	NULL
HLA-DRA	NULL
promoter	NULL
reporter	NULL
construct	NULL
.	NULL

We	NULL
generated	NULL
two	NULL
promoter	NULL
reporter	NULL
constructs	NULL
by	NULL
subcloning	NULL
the	NULL
-176	NULL
to	NULL
+45	NULL
region	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
(	NULL
19	NULL
)	NULL
into	NULL
pGL3	NULL
luciferase	NULL
vector	NULL
.	NULL

One	NULL
construct	NULL
has	NULL
the	NULL
wild-type	NULL
octamer	NULL
element	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
(	NULL
pDRAlucWT	NULL
)	NULL
,	NULL
and	NULL
the	NULL
other	NULL
construct	NULL
contains	NULL
the	NULL
mutant	NULL
octamer	NULL
element	NULL
generated	NULL
by	NULL
substituting	NULL
four	NULL
nucleotides	NULL
within	NULL
the	NULL
octamer	NULL
box	NULL
(	NULL
pDRAlucOCTmut	NULL
;	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
element	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
repressive	NULL
effect	NULL
on	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
nucleotide	NULL
substitutions	NULL
eliminate	NULL
this	NULL
repressive	NULL
effect	NULL
(	NULL
19	NULL
)	NULL
.	NULL

These	NULL
substitutions	NULL
also	NULL
represent	NULL
the	NULL
mutated	NULL
octamer	NULL
sequence	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
if	NULL
the	NULL
higher	NULL
level	NULL
of	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
Rb-defective	NULL
cells	NULL
affected	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
,	NULL
then	NULL
the	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
would	NULL
have	NULL
a	NULL
greater	NULL
effect	NULL
in	NULL
the	NULL
Rb-defective	NULL
cells	NULL
than	NULL
in	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
.	NULL

That	NULL
is	NULL
,	NULL
if	NULL
the	NULL
endogenous	NULL
Oct-1	NULL
differences	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
could	NULL
affect	NULL
promoter	NULL
activity	NULL
,	NULL
then	NULL
the	NULL
mutations	NULL
in	NULL
the	NULL
octamer	NULL
box	NULL
should	NULL
lead	NULL
to	NULL
a	NULL
greater	NULL
relief	NULL
of	NULL
repression	NULL
in	NULL
the	NULL
Rb-defective	NULL
cells	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
Rb-defective	NULL
5637	NULL
cells	NULL
and	NULL
the	NULL
Rb-transformed	NULL
subclone	NULL
12-27	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

In	NULL
the	NULL
Rb-defective	NULL
5637	NULL
cells	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
with	NULL
the	NULL
mutated	NULL
octamer	NULL
box	NULL
was	NULL
increased	NULL
by	NULL
1.7-fold	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
original	NULL
data	NULL
indicating	NULL
that	NULL
Oct-1	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
HLA-DRA	NULL
promoter	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
promoter	NULL
activity	NULL
between	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
promoter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
reduced	NULL
Oct-1	NULL
binding	NULL
in	NULL
this	NULL
Rb-transformed	NULL
cell	NULL
line	NULL
.	NULL

Increased	NULL
IL-8	NULL
Secretion	NULL
in	NULL
Rb-transformed	NULL
Cells	NULL
.	NULL

Oct-1	NULL
is	NULL
a	NULL
transcriptional	NULL
repressor	NULL
for	NULL
the	NULL
human	NULL
IL-8	NULL
gene	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
Rb	NULL
expression	NULL
also	NULL
relieves	NULL
the	NULL
repressive	NULL
effect	NULL
of	NULL
Oct-1	NULL
on	NULL
the	NULL
IL-8	NULL
promoter	NULL
.	NULL

First	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
reconstitution	NULL
of	NULL
Rb	NULL
in	NULL
the	NULL
Rb-defective	NULL
5637	NULL
cells	NULL
affects	NULL
the	NULL
amount	NULL
of	NULL
IL-8	NULL
secretion	NULL
.	NULL

Culture	NULL
media	NULL
was	NULL
collected	NULL
24	NULL
h	NULL
after	NULL
cell	NULL
plating	NULL
and	NULL
analyzed	NULL
by	NULL
ELISA	NULL
for	NULL
IL-8	NULL
,	NULL
which	NULL
revealed	NULL
that	NULL
IL-8	NULL
was	NULL
secreted	NULL
by	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
the	NULL
secretion	NULL
of	NULL
IL-8	NULL
was	NULL
increased	NULL
in	NULL
the	NULL
Rb-transformed	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
IL-8	NULL
secretion	NULL
from	NULL
the	NULL
Rb-transformed	NULL
subclone	NULL
12-27	NULL
is	NULL
1.6-fold	NULL
higher	NULL
than	NULL
that	NULL
for	NULL
144	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
paired	NULL
with	NULL
12-27	NULL
cells	NULL
as	NULL
the	NULL
Rb-defective	NULL
control	NULL
for	NULL
this	NULL
experiment	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IL-8	NULL
secretion	NULL
from	NULL
the	NULL
Rb-transformed	NULL
cell	NULL
line	NULL
10-1	NULL
was	NULL
5.3-fold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
the	NULL
Rb-defective	NULL
1¥1	NULL
subclones	NULL
,	NULL
paired	NULL
with	NULL
10-1	NULL
as	NULL
a	NULL
control	NULL
in	NULL
a	NULL
separate	NULL
experiment	NULL
.	NULL

The	NULL
Repressive	NULL
Effect	NULL
of	NULL
Oct-1	NULL
on	NULL
IL-8	NULL
Promoter	NULL
Activity	NULL
Is	NULL
Relieved	NULL
by	NULL
Rb	NULL
Expression	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
increased	NULL
IL-8	NULL
secretion	NULL
by	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
could	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
first	NULL
used	NULL
a	NULL
strategy	NULL
similar	NULL
to	NULL
the	NULL
strategy	NULL
used	NULL
in	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
Rb-related	NULL
Oct-1	NULL
differences	NULL
on	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
this	NULL
strategy	NULL
was	NULL
designed	NULL
to	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
endogenous	NULL
levels	NULL
of	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
on	NULL
IL-8	NULL
promoter	NULL
activity	NULL
.	NULL

IL-8	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
containing	NULL
a	NULL
wild-type	NULL
or	NULL
mutated	NULL
octamer	NULL
element	NULL
(	NULL
21	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
cells	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
parental	NULL
5637	NULL
cells	NULL
,	NULL
the	NULL
construct	NULL
with	NULL
the	NULL
mutated	NULL
oc-	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
8	NULL
£	NULL
TZ	NULL
a	NULL
§	NULL
$	NULL
3	NULL
£	NULL
2	NULL
°	NULL
3	NULL
&	NULL
s	NULL
5	NULL
3	NULL
3	NULL
a	NULL
T	NULL
2	NULL
T	NULL
E	NULL
E	NULL
8	NULL
§	NULL
1	NULL
A	NULL
~	NULL
sage-nu	NULL
$	NULL
5,552	NULL
,	NULL
3	NULL
1	NULL
%	NULL
«	NULL
Eks	NULL
C	NULL
3	NULL
f	NULL
2	NULL
%	NULL
a	NULL
46	NULL
a	NULL
@	NULL
°°s	NULL
S	NULL
Rb	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
C	NULL
IFN-y	NULL
--	NULL
-+	NULL
++	NULL
oct	NULL
=	NULL
>	NULL
M	NULL
#	NULL
>	NULL
a-	NULL
wr	NULL
'	NULL
Oct-1	NULL
mp	NULL
#	NULL
i+	NULL
(	NULL
WP	NULL
ww	NULL
'	NULL
NS	NULL
mp	NULL
ns	NULL
=p	NULL
w	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
B	NULL
pin	NULL
<	NULL
~	NULL
youd	NULL
}	NULL
_	NULL
youd	NULL
Y-box	NULL
blndlng	NULL
,	NULL
protein	NULL
.	NULL

H	NULL
P	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Oct-1	NULL
-	NULL
»	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Reduced	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
octamer	NULL
element	NULL
using	NULL
extracts	NULL
from	NULL
Rb-transformed	NULL
cells	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
26-bp	NULL
synthetic	NULL
oligonucleotide	NULL
including	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
octamer	NULL
element	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

A	NULL
,	NULL
cells	NULL
lines	NULL
are	NULL
as	NULL
indicated	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
Lanes	NULL
1-4	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
Oct-1-DNA	NULL
complex	NULL
was	NULL
verified	NULL
by	NULL
antibody	NULL
supershift	NULL
(	NULL
Lanes	NULL
6-8	NULL
)	NULL
and	NULL
binding	NULL
competition	NULL
using	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
and	NULL
octamer-mutated	NULL
oligonucleotides	NULL
(	NULL
Lanes	NULL
9-72	NULL
)	NULL
using	NULL
nuclear	NULL
extract	NULL
from	NULL
the	NULL
14	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
using	NULL
extracts	NULL
from	NULL
1A4	NULL
and	NULL
12-27	NULL
cells	NULL
and	NULL
the	NULL
HLA-DRA	NULL
Y	NULL
box	NULL
as	NULL
probe	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
top	NULL
panel	NULL
.	NULL

Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
for	NULL
the	NULL
same	NULL
extracts	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
bottom	NULL
panel	NULL
.	NULL

C	NULL
,	NULL
cells	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
Lanes	NULL
1-3	NULL
;	NULL
5637	NULL
,	NULL
1A4	NULL
,	NULL
and	NULL
12-27	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
400	NULL
units/ml	NULL
IFN-y	NULL
(	NULL
Lanes	NULL
4-6	NULL
;	NULL
5637	NULL
,	NULL
1¥4	NULL
,	NULL
and	NULL
12-27	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
arrow	NULL
indicates	NULL
the	NULL
Oct-1-DNA	NULL
complex	NULL
.	NULL

The	NULL
lower	NULL
arrow	NULL
indicates	NULL
a	NULL
nonspecific	NULL
protein-DNA	NULL
complex	NULL
(	NULL
NS	NULL
)	NULL
.	NULL

tamer	NULL
element	NULL
had	NULL
a	NULL
2.5-fold	NULL
higher	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
Rb-transformed	NULL
subclone	NULL
12-27	NULL
,	NULL
there	NULL
was	NULL
a	NULL
1.5-fold	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
for	NULL
the	NULL
construct	NULL
with	NULL
the	NULL
mutated	NULL
octamer	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Northern	NULL
blotting	NULL
was	NULL
performed	NULL
to	NULL
be	NULL
certain	NULL
that	NULL
the	NULL
increased	NULL
level	NULL
of	NULL
IL-8	NULL
secretion	NULL
by	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
reflected	NULL
an	NULL
increase	NULL
in	NULL
IL-8	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
mRNA	NULL
bands	NULL
were	NULL
quantified	NULL
and	NULL
normalized	NULL
to	NULL
28S	NULL
rRNA	NULL
.	NULL

Setting	NULL
the	NULL
ratio	NULL
of	NULL
IL-8	NULL
mRNA:28S	NULL
rRNA	NULL
in	NULL
parental	NULL
5637	NULL
cells	NULL
as	NULL
1	NULL
,	NULL
we	NULL
observed	NULL
relative	NULL
ratios	NULL
of	NULL
1.73	NULL
and	NULL
4.23	NULL
in	NULL
the	NULL
Rb-defective	NULL
1A4	NULL
subclone	NULL
and	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
subclone	NULL
,	NULL
respectively	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Oct-1	NULL
Binding	NULL
to	NULL
the	NULL
IL-8	NULL
Promoter	NULL
Octamer	NULL
Element	NULL
Is	NULL
Reduced	NULL
in	NULL
Rb-transformed	NULL
Cells	NULL
.	NULL

As	NULL
indicated	NULL
above	NULL
,	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
octamer	NULL
element	NULL
is	NULL
reduced	NULL
in	NULL
Rb-transformed	NULL
cells	NULL
.	NULL

One	NULL
report	NULL
(	NULL
22	NULL
)	NULL
has	NULL
indicated	NULL
that	NULL
different	NULL
kinase	NULL
activities	NULL
leading	NULL
to	NULL
Oct-1	NULL
phosphorylation	NULL
might	NULL
differentially	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
Oct-1	NULL
to	NULL
different	NULL
octamer	NULL
elements	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
Oct-1/IL-8	NULL
octamer	NULL
box	NULL
binding	NULL
was	NULL
similarly	NULL
reduced	NULL
in	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
,	NULL
an	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
parental	NULL
5637	NULL
cell	NULL
line	NULL
and	NULL
its	NULL
subclones	NULL
144	NULL
and	NULL
12-27	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

A	NULL
20-bp	NULL
double-stranded	NULL
oligonucleotide	NULL
including	NULL
the	NULL
human	NULL
IL-8	NULL
gene	NULL
promoter	NULL
octamer	NULL
element	NULL
was	NULL
used	NULL
as	NULL
459	NULL
460	NULL
_	NULL
Rb	NULL
Regulation	NULL
of	NULL
Oct-1	NULL
and	NULL
IL-8	NULL
aa	NULL
bo	NULL
so	NULL
5637	NULL
12-27	NULL
\o	NULL
&	NULL
Light	NULL
Units	NULL
(	NULL
x	NULL
10°	NULL
)	NULL
Cat	NULL
Light	NULL
Units	NULL
(	NULL
x	NULL
10°	NULL
)	NULL
Ja	NULL
uo	NULL
bo	NULL
wild-type	NULL
-	NULL
mutant	NULL
wild-type	NULL
-	NULL
mutant	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Repressive	NULL
effect	NULL
of	NULL
Oct-1	NULL
on	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
relieved	NULL
by	NULL
Rb	NULL
expression	NULL
.	NULL

The	NULL
wild-type	NULL
(	NULL
pDRAlucWT	NULL
)	NULL
or	NULL
octamer-mutated	NULL
HLA-DRA	NULL
(	NULL
pDRAlucOCTmut	NULL
)	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
Rb-defective	NULL
5637	NULL
cells	NULL
or	NULL
the	NULL
Rb-transformed	NULL
subclone	NULL
,	NULL
12-27	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
by	NULL
scintillation	NULL
counting	NULL
.	NULL

In	NULL
5637	NULL
cells	NULL
,	NULL
the	NULL
mutant	NULL
construct	NULL
had	NULL
a	NULL
1.7-fold	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
construct	NULL
.	NULL

In	NULL
12-27	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
promoter	NULL
activity	NULL
between	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
constructs	NULL
.	NULL

1200	NULL
900	NULL
€	NULL
B0	NULL
&	NULL
-	NULL
e00	NULL
<	NULL
F	NULL
&	NULL
©	NULL
ast	NULL
300	NULL
{	NULL
0	NULL
P	NULL
1A4	NULL
1A1	NULL
-	NULL
12-27	NULL
10-1	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

IL-8	NULL
secretion	NULL
by	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
subclones	NULL
.	NULL

Each	NULL
5637	NULL
subclone	NULL
was	NULL
plated	NULL
in	NULL
triplicate	NULL
,	NULL
and	NULL
culture	NULL
media	NULL
were	NULL
collected	NULL
at	NULL
24	NULL
h	NULL
after	NULL
plating	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
IL-8	NULL
in	NULL
the	NULL
culture	NULL
media	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
,	NULL
and	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
triplicate	NULL
samples	NULL
.	NULL

a	NULL
probe	NULL
.	NULL

Oct-1	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
for	NULL
5637	NULL
and	NULL
1A4	NULL
cells	NULL
but	NULL
was	NULL
not	NULL
detectable	NULL
for	NULL
the	NULL
Rb-transformed	NULL
cell	NULL
line	NULL
12-27	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

Binding	NULL
competition	NULL
with	NULL
the	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutated	NULL
octamer	NULL
probe	NULL
and	NULL
Oct-1	NULL
antibody	NULL
supershift	NULL
confirmed	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
Oct-1/	NULL
DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
Lanes	NULL
5-8	NULL
)	NULL
.	NULL

Culture	NULL
Media	NULL
from	NULL
the	NULL
Rb-transformed	NULL
Cells	NULL
Enhances	NULL
Neutrophil	NULL
Migration	NULL
.	NULL

IL-8	NULL
is	NULL
a	NULL
potent	NULL
chemotactic	NULL
factor	NULL
for	NULL
neutrophils	NULL
and	NULL
lymphocytes	NULL
.	NULL

It	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
angiogenesis	NULL
and	NULL
metastasis	NULL
of	NULL
some	NULL
tumors	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
a	NULL
possible	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
differences	NULL
in	NULL
IL-8	NULL
secretion	NULL
among	NULL
the	NULL
5637	NULL
subclones	NULL
,	NULL
we	NULL
used	NULL
a	NULL
microwell	NULL
chemotaxis	NULL
chamber	NULL
assay	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
the	NULL
chemotactic	NULL
agent	NULL
(	NULL
f.e	NULL
.	NULL

,	NULL
culture	NULL
media	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
)	NULL
and	NULL
neutrophils	NULL
were	NULL
separated	NULL
by	NULL
a	NULL
polycarbonate	NULL
filter	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
filter	NULL
,	NULL
which	NULL
trapped	NULL
5637	NULL
12-27	NULL
30	NULL
30	NULL
&	NULL
``	NULL
o	NULL
I	NULL
re	NULL
x	NULL
a	NULL
y	NULL
20	NULL
£20	NULL
uE	NULL
D	NULL
=	NULL
3	NULL
o	NULL
jis	NULL
3	NULL
10	NULL
10	NULL
0	NULL
0	NULL
wild-type	NULL
-	NULL
mutant	NULL
wild-type	NULL
-	NULL
mutant	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Repressive	NULL
effect	NULL
of	NULL
Oct-1	NULL
on	NULL
HLA-DRA	NULL
promoter	NULL
activity	NULL
relieved	NULL
by	NULL
Rb	NULL
expression	NULL
.	NULL

The	NULL
wild-type	NULL
or	NULL
octamer-mutated	NULL
IL-8	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
Rb-defective	NULL
5637	NULL
cells	NULL
or	NULL
the	NULL
Rb-transformed	NULL
subclone	NULL
,	NULL
12-27	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

In	NULL
5637	NULL
cells	NULL
,	NULL
the	NULL
octamer-mutated	NULL
IL-8	NULL
promoter	NULL
construct	NULL
had	NULL
a	NULL
2.5-fold	NULL
increased	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
.	NULL

In	NULL
12-27	NULL
cells	NULL
,	NULL
the	NULL
mutant	NULL
construct	NULL
had	NULL
a	NULL
1.5-fold	NULL
increase	NULL
in	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
construct	NULL
.	NULL

Table	NULL
2	NULL
IL-8	NULL
mRNA	NULL
in	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
cells*	NULL
5637	NULL
(	NULL
Rb-	NULL
)	NULL
144	NULL
(	NULL
Rb-	NULL
)	NULL
12-27	NULL
(	NULL
Rb+	NULL
)	NULL
mRNA	NULL
88.2	NULL
109.3	NULL
149.7	NULL
28S	NULL
rRNA	NULL
170.8	NULL
121.0	NULL
68.1	NULL
mRNA	NULL
:	NULL
rRNA	NULL
0.52	NULL
0.90	NULL
2.20	NULL
Relative	NULL
ratio	NULL
1.00	NULL
1.73	NULL
4.23	NULL
``	NULL
The	NULL
intensities	NULL
of	NULL
the	NULL
mRNA	NULL
bands	NULL
from	NULL
Northern	NULL
blotting	NULL
and	NULL
the	NULL
28S	NULL
rRNA	NULL
bands	NULL
stained	NULL
by	NULL
ethidium	NULL
bromide	NULL
were	NULL
quantified	NULL
by	NULL
ImageQuaNT	NULL
computer	NULL
software	NULL
.	NULL

The	NULL
relative	NULL
mRNA:28S	NULL
rRNA	NULL
ratio	NULL
in	NULL
the	NULL
5637	NULL
cells	NULL
was	NULL
set	NULL
as	NULL
1.00.	NULL
migrated	NULL
neutrophils	NULL
,	NULL
was	NULL
then	NULL
washed	NULL
and	NULL
stained	NULL
.	NULL

Migrated	NULL
neutrophils	NULL
on	NULL
the	NULL
filter	NULL
were	NULL
microscopically	NULL
evaluated	NULL
and	NULL
counted	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
;	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
migrated	NULL
neutrophils	NULL
was	NULL
increased	NULL
by	NULL
culture	NULL
media	NULL
from	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
compare	NULL
D	NULL
with	NULL
C	NULL
)	NULL
.	NULL

Table	NULL
3	NULL
shows	NULL
the	NULL
neutrophil	NULL
migration	NULL
rates	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

In	NULL
one	NULL
experiment	NULL
,	NULL
a	NULL
1:1	NULL
dilution	NULL
of	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
culture	NULL
media	NULL
led	NULL
to	NULL
a	NULL
migration	NULL
rate	NULL
of	NULL
30	NULL
%	NULL
versus	NULL
2	NULL
%	NULL
for	NULL
a	NULL
1:1	NULL
dilution	NULL
of	NULL
the	NULL
Rb-defective	NULL
144	NULL
culture	NULL
media	NULL
.	NULL

Additional	NULL
experiments	NULL
indicated	NULL
similar	NULL
differences	NULL
in	NULL
the	NULL
migration	NULL
rates	NULL
generated	NULL
by	NULL
culture	NULL
media	NULL
from	NULL
Rb-transformed	NULL
versus	NULL
Rb-defective	NULL
cell	NULL
lines	NULL
.	NULL

Hyperphosphorylation	NULL
of	NULL
Oct-1	NULL
in	NULL
Rb-transformed	NULL
Tumor	NULL
Cells	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
mechanism	NULL
of	NULL
reduced	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
and	NULL
IL-8	NULL
octamer	NULL
elements	NULL
(	NULL
Figs	NULL
.	NULL

1A	NULL
and	NULL
5	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blotting	NULL
to	NULL
evaluate	NULL
Oct-1	NULL
protein	NULL
levels	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
subclones	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
Oct-1	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
Rb-defective	NULL
1A4	NULL
and	NULL
1A1	NULL
subclones	NULL
and	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
and	NULL
10-1	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

74	NULL
)	NULL
,	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
differences	NULL
in	NULL
Oct-1	NULL
protein	NULL
levels	NULL
accounted	NULL
for	NULL
promoter	NULL
binding	NULL
differences	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
10	NULL
X	NULL
wt	NULL
10	NULL
X	NULL
mut	NULL
EGFR	NULL
Ab	NULL
12-27	NULL
t-F	NULL
C	NULL
``	NULL
,	NULL
\o	NULL
4	NULL
U	NULL
)	NULL
8	NULL
Oct-1	NULL
Ab	NULL
Oct-1	NULL
=p	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Oct-1	NULL
binding	NULL
to	NULL
the	NULL
IL-8	NULL
promoter	NULL
octamer	NULL
element	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
and	NULL
the	NULL
probe	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
is	NULL
a	NULL
20-bp	NULL
synthetic	NULL
oligonucleotide	NULL
including	NULL
the	NULL
IL-8	NULL
promoter	NULL
octamer	NULL
element	NULL
.	NULL

Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
extracts	NULL
from	NULL
the	NULL
Rb-defective	NULL
parental	NULL
5637	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
1¥4	NULL
subclone	NULL
(	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
and	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
nearly	NULL
absent	NULL
in	NULL
extracts	NULL
from	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
cells	NULL
(	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
Oct-1-DNA	NULL
complex	NULL
was	NULL
verified	NULL
by	NULL
binding	NULL
competition	NULL
(	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
antibody	NULL
supershift	NULL
(	NULL
Lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
large	NULL
complex	NULL
below	NULL
Oct-1	NULL
binds	NULL
both	NULL
the	NULL
octamer	NULL
element	NULL
and	NULL
the	NULL
mutated	NULL
octamer	NULL
element	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
nonspecific	NULL
.	NULL

However	NULL
,	NULL
the	NULL
complex	NULL
is	NULL
apparently	NULL
disrupted	NULL
by	NULL
the	NULL
anti-Oct-1	NULL
antibody	NULL
,	NULL
for	NULL
unknown	NULL
reasons	NULL
.	NULL

Because	NULL
phosphorylation	NULL
of	NULL
Oct-1	NULL
reduces	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
22	NULL
,	NULL
25	NULL
)	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
Oct-1	NULL
in	NULL
the	NULL
5637	NULL
subclones	NULL
.	NULL

Cultured	NULL
cells	NULL
were	NULL
metabolically	NULL
labeled	NULL
by	NULL
[	NULL
°PJorthophosphate	NULL
,	NULL
Oct-1	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
nuclear	NULL
extracts	NULL
by	NULL
anti-Oct-1	NULL
monoclonal	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
(	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

Results	NULL
revealed	NULL
that	NULL
Oct-1	NULL
was	NULL
phosphorylated	NULL
in	NULL
both	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
,	NULL
but	NULL
that	NULL
phosphorylation	NULL
of	NULL
Oct-1	NULL
was	NULL
increased	NULL
in	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
subclone	NULL
at	NULL
24	NULL
h	NULL
and	NULL
48	NULL
h	NULL
after	NULL
plating	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

This	NULL
same	NULL
gel	NULL
was	NULL
then	NULL
transferred	NULL
and	NULL
blotted	NULL
with	NULL
anti-Oct-1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
to	NULL
determine	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
Oct-1	NULL
.	NULL

Oct-1	NULL
phosphorylation	NULL
levels	NULL
in	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
subclones	NULL
were	NULL
quantified	NULL
and	NULL
normalized	NULL
to	NULL
total	NULL
Oct-1	NULL
as	NULL
detected	NULL
by	NULL
the	NULL
Western	NULL
analysis	NULL
(	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

Setting	NULL
the	NULL
Oct-1	NULL
phosphorylation	NULL
levels	NULL
(	NULL
phosphorylated	NULL
Oct-1	NULL
:	NULL
total	NULL
Oct-1	NULL
)	NULL
in	NULL
the	NULL
Rb-defective	NULL
1A4	NULL
subclone	NULL
at	NULL
24	NULL
h	NULL
after	NULL
plating	NULL
as	NULL
1	NULL
,	NULL
we	NULL
obtained	NULL
a	NULL
relative	NULL
level	NULL
of	NULL
1.7	NULL
in	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
subclone	NULL
cultured	NULL
during	NULL
the	NULL
same	NULL
time	NULL
period	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
Oct-1	NULL
phosphorylation	NULL
between	NULL
the	NULL
1¥4	NULL
and	NULL
12-27	NULL
cells	NULL
remained	NULL
constant	NULL
at	NULL
48	NULL
h	NULL
after	NULL
plating	NULL
(	NULL
Table	NULL
4	NULL
)	NULL
.	NULL

Discussion	NULL
Relief	NULL
of	NULL
Oct-1-mediated	NULL
Repression	NULL
by	NULL
Rb	NULL
.	NULL

The	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
Oct-1	NULL
functions	NULL
as	NULL
either	NULL
a	NULL
positive	NULL
or	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
genes	NULL
for	NULL
snRNA	NULL
(	NULL
26	NULL
)	NULL
,	NULL
H2B	NULL
(	NULL
27	NULL
)	NULL
,	NULL
immunoglobulin	NULL
(	NULL
28	NULL
)	NULL
,	NULL
CD11	NULL
(	NULL
29	NULL
)	NULL
,	NULL
CD20	NULL
(	NULL
30	NULL
)	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
dependent	NULL
on	NULL
Oct-1	NULL
interaction	NULL
with	NULL
the	NULL
octamer	NULL
motifs	NULL
(	NULL
ATTTGCAT	NULL
or	NULL
its	NULL
vari-ants	NULL
)	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
or	NULL
enhancers	NULL
(	NULL
27	NULL
,	NULL
28	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
genes	NULL
regulated	NULL
by	NULL
Oct-1	NULL
encode	NULL
products	NULL
participating	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
processes	NULL
,	NULL
ranging	NULL
from	NULL
housekeeping	NULL
to	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
27	NULL
,	NULL
28	NULL
,	NULL
32	NULL
)	NULL
.	NULL

As	NULL
discussed	NULL
above	NULL
,	NULL
IFN-y	NULL
treatment	NULL
of	NULL
Rb-defective	NULL
cells	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
HLA	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
or	NULL
leads	NULL
to	NULL
only	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

Rb	NULL
expression	NULL
rescues	NULL
HLA	NULL
class	NULL
II	NULL
inducibility	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Data	NULL
described	NULL
in	NULL
this	NULL
report	NULL
indicate	NULL
that	NULL
the	NULL
repressive	NULL
effect	NULL
of	NULL
Oct-1	NULL
on	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
is	NULL
alleviated	NULL
by	NULL
reconstitution	NULL
of	NULL
functional	NULL
Rb	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
relief	NULL
of	NULL
Oct-1-mediated	NULL
repression	NULL
is	NULL
unlikely	NULL
to	NULL
represent	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
entire	NULL
effect	NULL
of	NULL
Rb	NULL
on	NULL
the	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
because	NULL
HLA-DRB	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
other	NULL
polypeptide	NULL
of	NULL
the	NULL
HLA-DR	NULL
molecule	NULL
,	NULL
does	NULL
not	NULL
have	NULL
an	NULL
octamer	NULL
site	NULL
in	NULL
its	NULL
promoter	NULL
.	NULL

Also	NULL
,	NULL
no	NULL
octamer	NULL
sites	NULL
have	NULL
been	NULL
described	NULL
for	NULL
the	NULL
HLA-DP	NULL
genes	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
which	NULL
is	NULL
also	NULL
dependent	NULL
on	NULL
Rb	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
HLA-DRA	NULL
gene	NULL
seems	NULL
more	NULL
heavily	NULL
dependent	NULL
on	NULL
Rb	NULL
than	NULL
do	NULL
other	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
9	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
possibility	NULL
that	NULL
Oct-1-mediated	NULL
repression	NULL
and	NULL
a	NULL
second	NULL
Rb-related	NULL
mechanism	NULL
simultaneously	NULL
regulate	NULL
HLA-DRA	NULL
induction	NULL
.	NULL

Oct-1	NULL
is	NULL
also	NULL
a	NULL
transcriptional	NULL
repressor	NULL
of	NULL
the	NULL
IL-8	NULL
promoter	NULL
,	NULL
in	NULL
which	NULL
a	NULL
variant	NULL
of	NULL
the	NULL
octamer	NULL
element	NULL
overlaps	NULL
a	NULL
CCAAT-enhancer-binding	NULL
protein	NULL
binding	NULL
site	NULL
(	NULL
21	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
,	NULL
the	NULL
repressive	NULL
effect	NULL
of	NULL
Oct-1	NULL
on	NULL
the	NULL
IL-8	NULL
promoter	NULL
is	NULL
relieved	NULL
by	NULL
expression	NULL
of	NULL
Rb	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
with	NULL
the	NULL
expected	NULL
consequence	NULL
of	NULL
higher	NULL
levels	NULL
of	NULL
IL-8	NULL
production	NULL
by	NULL
Rb-transformed	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
report	NULL
that	NULL
the	NULL
IL-8	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
Rb	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Oct-1	NULL
by	NULL
Rb	NULL
Expression	NULL
.	NULL

The	NULL
Western	NULL
blotting	NULL
and	NULL
immunoprecipitation	NULL
analyses	NULL
of	NULL
Oct-1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
revealed	NULL
that	NULL
Oct-1	NULL
is	NULL
hyperphosphorylated	NULL
in	NULL
Rb-transformed	NULL
cells	NULL
,	NULL
which	NULL
explains	NULL
the	NULL
reduced	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
HLA-DRA	NULL
and	NULL
IL-8	NULL
promoters	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Other	NULL
than	NULL
Rb	NULL
expression	NULL
,	NULL
only	NULL
one	NULL
process	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
alter	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
or	NULL
phosphorylation	NULL
:	NULL
mitosis	NULL
(	NULL
25	NULL
,	NULL
33	NULL
)	NULL
.	NULL

In	NULL
mitosis	NULL
,	NULL
Oct-1	NULL
becomes	NULL
highly	NULL
phosphorylated	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
loss	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Although	NULL
phosphorylation	NULL
of	NULL
Oct-1	NULL
by	NULL
either	NULL
protein	NULL
kinase	NULL
A	NULL
or	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
22	NULL
)	NULL
in	NULL
vitro	NULL
reduces	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
octamer	NULL
element	NULL
,	NULL
the	NULL
Oct-1	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
that	NULL
functions	NULL
in	NULL
vivo	NULL
is	NULL
unknown	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Oct-1	NULL
and	NULL
Growth	NULL
Control	NULL
.	NULL

Oct-1	NULL
is	NULL
a	NULL
transactivator	NULL
involved	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
regulation	NULL
of	NULL
H2B	NULL
gene	NULL
transcription	NULL
and	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
snRNA	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
presumably	NULL
important	NULL
for	NULL
rapid	NULL
cell	NULL
division	NULL
.	NULL

Re-expression	NULL
of	NULL
Rb	NULL
in	NULL
the	NULL
Rb-defective	NULL
tumor	NULL
cells	NULL
probably	NULL
leads	NULL
to	NULL
reduced	NULL
Oct-1	NULL
binding	NULL
to	NULL
the	NULL
H2B	NULL
and	NULL
snRNA	NULL
promoters	NULL
,	NULL
facilitating	NULL
Rb-mediated	NULL
G	NULL
,	NULL
growth	NULL
arrest	NULL
.	NULL

If	NULL
so	NULL
,	NULL
this	NULL
would	NULL
be	NULL
the	NULL
first	NULL
E2F-independent	NULL
link	NULL
between	NULL
Rb	NULL
and	NULL
growth	NULL
control	NULL
.	NULL

However	NULL
,	NULL
this	NULL
proposal	NULL
is	NULL
not	NULL
supported	NULL
by	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
H2B	NULL
gene	NULL
regulation	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
H2B	NULL
mRNA	NULL
stability	NULL
,	NULL
not	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Oct-1	NULL
is	NULL
thought	NULL
to	NULL
effect	NULL
only	NULL
a	NULL
minor	NULL
increase	NULL
in	NULL
H2B	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
Oct-1	NULL
is	NULL
required	NULL
for	NULL
basal	NULL
level	NULL
H2B	NULL
or	NULL
snRNA	NULL
transcription	NULL
.	NULL

Reso-	NULL
462	NULL
-	NULL
Rb	NULL
Regulation	NULL
of	NULL
Oct-1	NULL
and	NULL
IL-8	NULL
a	NULL
,6	NULL
ﬁo	NULL
tri	NULL
ja	NULL
to	NULL
``	NULL
Cta	NULL
/	NULL
MIE	NULL
EAL	NULL
``	NULL
g	NULL
!	NULL

\	NULL
&	NULL
x	NULL
os	NULL
no	NULL
WR	NULL
a	NULL
)	NULL
©	NULL
K	NULL
p	NULL
$	NULL
40	NULL
3	NULL
~	NULL
a	NULL
5	NULL
#	NULL
*	NULL
m*	NULL
s	NULL
to	NULL
¥	NULL
,	NULL
,	NULL
a_	NULL
{	NULL
\¢q	NULL
A	NULL
av	NULL
i.	NULL
s	NULL
$	NULL
a	NULL
o	NULL
m	NULL
B5	NULL
t*	NULL
,	NULL
d	NULL
rag/9	NULL
$	NULL
_	NULL
t	NULL
p27	NULL
3	NULL
°goé°	NULL
?	NULL

m	NULL
‘	NULL
l-°-°h3iw—f\	NULL
``	NULL
'	NULL
%	NULL
a	NULL
4°	NULL
éuof	NULL
o	NULL
p	NULL
Q6e	NULL
‘	NULL
néﬁ	NULL
’	NULL
é	NULL
‘	NULL
&	NULL
®	NULL
“	NULL
£30me	NULL
§	NULL
c.	NULL
“	NULL
ecc'noz	NULL
a	NULL
th	NULL
0	NULL
90	NULL
‘	NULL
5	NULL
“	NULL
hm	NULL
960,0	NULL
’	NULL
o	NULL
08	NULL
P.	NULL
be	NULL
y	NULL
i	NULL
{	NULL
6	NULL
'	NULL
>	NULL
%	NULL
«	NULL
@	NULL
1	NULL
?	NULL

,	NULL
``	NULL
C9.Q	NULL
'	NULL
a	NULL
«	NULL
uso	NULL
d	NULL
fig-ti	NULL
)	NULL
“	NULL
i§§	NULL
(	NULL
3	NULL
&	NULL
4	NULL
?	NULL

.tﬂ	NULL
$	NULL
90	NULL
5.3	NULL
“	NULL
ﬂ	NULL
gsmdg	NULL
o	NULL
:	NULL
1	NULL
;	NULL
£	NULL
cs	NULL
‘	NULL
wio	NULL
‘	NULL
i	NULL
ﬂu	NULL
“	NULL
5:0	NULL
]	NULL
°°	NULL
R	NULL
‘	NULL
s-7°	NULL
$	NULL
2	NULL
”	NULL
at	NULL
,	NULL
ﬂ	NULL
A	NULL
6	NULL
)	NULL
n'rﬁ	NULL
#	NULL
6	NULL
.	NULL

0°	NULL
aP	NULL
Lint	NULL
oe	NULL
t.a	NULL
P	NULL
*~2	NULL
E	NULL
6	NULL
§	NULL
Ind	NULL
af	NULL
=	NULL
00	NULL
%	NULL
4	NULL
$	NULL
a	NULL
6	NULL
ge	NULL
»	NULL
'	NULL
``	NULL
®	NULL
es	NULL
64	NULL
o	NULL
;	NULL
9	NULL
%	NULL
,	NULL
%	NULL
,	NULL
61s	NULL
,	NULL
o	NULL
>	NULL
*	NULL
gs	NULL
``	NULL
o	NULL
§	NULL
``	NULL
*°°\	NULL
'	NULL
a\	NULL
$	NULL
3	NULL
“	NULL
(	NULL
Sagan	NULL
a	NULL
?	NULL

g€	NULL
‘	NULL
xﬁ	NULL
'	NULL
“	NULL
Yo	NULL
.	NULL

M0	NULL
“	NULL
¢	NULL
°	NULL
ﬁg	NULL
“	NULL
;	NULL
a	NULL
.	NULL

»	NULL
``	NULL
_	NULL
‘	NULL
n.fw	NULL
3	NULL
rh00°€	NULL
’	NULL
ez	NULL
A	NULL
0091	NULL
?	NULL

”	NULL
L	NULL
:	NULL
``	NULL
$	NULL
$	NULL
\g	NULL
&	NULL
a	NULL
'	NULL
%	NULL
``	NULL
.	NULL

'as	NULL
in	NULL
(	NULL
a.	NULL
o.	NULL
,	NULL
$	NULL
092	NULL
;	NULL
«	NULL
t	NULL
%	NULL
?	NULL

§	NULL
&	NULL
HQJQOJ°	NULL
'	NULL
c	NULL
a	NULL
#	NULL
ep	NULL
f	NULL
;	NULL
%	NULL
!	NULL

,	NULL
e®	NULL
06.9	NULL
:	NULL
“	NULL
qt	NULL
,	NULL
anK/wzo	NULL
``	NULL
ta	NULL
(	NULL
a	NULL
®	NULL
U	NULL
o-	NULL
€	NULL
wo	NULL
*	NULL
9	NULL
%	NULL
0	NULL
%	NULL
0	NULL
=o	NULL
a*	NULL
p	NULL
&	NULL
<	NULL
(	NULL
K	NULL
|	NULL
``	NULL
$	NULL
S	NULL
-s°	NULL
:	NULL
>	NULL
$	NULL
$	NULL
°	NULL
Bog	NULL
``	NULL
37'90	NULL
?	NULL

``	NULL
``	NULL
s	NULL
‘	NULL
d	NULL
’	NULL
ﬁ	NULL
”	NULL
eéagﬁ	NULL
,	NULL
’	NULL
gig	NULL
;	NULL
33	NULL
.	NULL

sie	NULL
\y	NULL
«	NULL
#	NULL
.	NULL

be	NULL
0	NULL
a_	NULL
ey	NULL
a	NULL
”	NULL
a	NULL
*	NULL
e*	NULL
``	NULL
rb	NULL
$	NULL
35	NULL
A	NULL
o	NULL
«	NULL
5°C	NULL
*w	NULL
gal	NULL
”	NULL
?	NULL

*	NULL
»	NULL
00:2	NULL
wk	NULL
``	NULL
79°\	NULL
“	NULL
Do°v	NULL
;	NULL
‘	NULL
.gab	NULL
ng	NULL
‘	NULL
i	NULL
'	NULL
ﬁ	NULL
``	NULL
a	NULL
?	NULL

“	NULL
*	NULL
$	NULL
part	NULL
``	NULL
``	NULL
Sad	NULL
rt	NULL
Lire	NULL
``	NULL
.A	NULL
ary	NULL
``	NULL
>	NULL
‘	NULL
vi	NULL
'	NULL
(	NULL
J	NULL
66°65	NULL
)	NULL
“	NULL
enhﬁso	NULL
‘	NULL
k	NULL
``	NULL
``	NULL
f	NULL
@	NULL
‘	NULL
:8	NULL
&	NULL
'	NULL
?	NULL

.e°0	NULL
“	NULL
lab-03	NULL
C	NULL
>	NULL
Lito	NULL
c	NULL
sys	NULL
a	NULL
*	NULL
-	NULL
ng	NULL
``	NULL
.	NULL

etl	NULL
ee	NULL
?	NULL

a	NULL
*	NULL
*	NULL
``	NULL
0	NULL
N	NULL
*	NULL
C.	NULL
A	NULL
£	NULL
6	NULL
%	NULL
.	NULL

0	NULL
Lao	NULL
Aine	NULL
.	NULL
``	NULL

86	NULL
iad	NULL
i	NULL
o	NULL
``	NULL
Fo	NULL
hPa	NULL
ol	NULL
48	NULL
Saor	NULL
}	NULL
Px	NULL
ao	NULL
sa	NULL
g	NULL
a	NULL
C37	NULL
as	NULL
``	NULL
FAG	NULL
am	NULL
``	NULL
5	NULL
7	NULL
-	NULL
=1	NULL
zo	NULL
pixs	NULL
t	NULL
``	NULL
``	NULL
te	NULL
war	NULL
LHG	NULL
-C	NULL
3	NULL
$	NULL
pV	NULL
``	NULL
“	NULL
H	NULL
“	NULL
©	NULL
sf	NULL
“	NULL
:	NULL
o°pac°w£~	NULL
&	NULL
ls	NULL
;	NULL
0	NULL
»	NULL
0	NULL
,	NULL
@	NULL
t'gqiﬂ	NULL
’	NULL
Je	NULL
$	NULL
07§¢§Z	NULL
&	NULL
:	NULL
“	NULL
°	NULL
of	NULL
?	NULL
)	NULL

pfﬂad	NULL
EAQI	NULL
‘	NULL
(	NULL
°3	NULL
“	NULL
‘	NULL
at	NULL
?	NULL

“	NULL
a	NULL
,	NULL
€	NULL
?	NULL

%	NULL
%	NULL
q	NULL
*	NULL
,	NULL
“	NULL
sf-001	NULL
,	NULL
i	NULL
“	NULL
J	NULL
:	NULL
2	NULL
#	NULL
!	NULL

c	NULL
6	NULL
``	NULL
oo	NULL
oy	NULL
ote	NULL
g	NULL
0	NULL
tux	NULL
C	NULL
2	NULL
%	NULL
.c	NULL
%	NULL
,	NULL
Set	NULL
@	NULL
CL	NULL
»	NULL
e	NULL
$	NULL
%	NULL
sh	NULL
q	NULL
.	NULL

``	NULL
o	NULL
0	NULL
Woo	NULL
o	NULL
ge0	NULL
``	NULL
§	NULL
9	NULL
l	NULL
's	NULL
(	NULL
``	NULL
D	NULL
,	NULL
9	NULL
be	NULL
~	NULL
y	NULL
o	NULL
o	NULL
-Ca	NULL
ld	NULL
#	NULL
``	NULL
o	NULL
20	NULL
94	NULL
8	NULL
ay	NULL
Messy	NULL
-	NULL
ma	NULL
``	NULL
a	NULL
,	NULL
>	NULL
g	NULL
's	NULL
e	NULL
¢	NULL
``	NULL
C	NULL
&	NULL
*	NULL
>	NULL
434	NULL
>	NULL
0	NULL
mg	NULL
2	NULL
)	NULL
o	NULL
B	NULL
,	NULL
%	NULL
a:8	NULL
a	NULL
¢	NULL
\	NULL
$	NULL
0	NULL
Eos	NULL
bo	NULL
0	NULL
gfmﬁsoqe	NULL
ta	NULL
?	NULL

8	NULL
a	NULL
's	NULL
$	NULL
*	NULL
*	NULL
an	NULL
,	NULL
.	NULL

>	NULL
£7453	NULL
a	NULL
9	NULL
C	NULL
ant	NULL
aod	NULL
E+	NULL
C	NULL
&	NULL
choy	NULL
..	NULL
,	NULL
X	NULL
1'7e/7ﬁgﬁ	NULL
’	NULL
9pii	NULL
'	NULL
i	NULL
cro	NULL
{	NULL
was	NULL
#	NULL
\	NULL
‘	NULL
°	NULL
$	NULL
o	NULL
Fy	NULL
SS	NULL
0432	NULL
?	NULL

alg	NULL
«	NULL
``	NULL
o	NULL
3	NULL
Cett	NULL
~*	NULL
6	NULL
.	NULL

``	NULL
or	NULL
o	NULL
®	NULL
P	NULL
a	NULL
be	NULL
S00	NULL
~-	NULL
tth	NULL
\	NULL
``	NULL
cP	NULL
®	NULL
F	NULL
ofa	NULL
2a	NULL
op	NULL
«	NULL
9	NULL
%	NULL
a	NULL
$	NULL
@	NULL
.	NULL

6	NULL
p	NULL
C	NULL
’	NULL
\\°W__	NULL
w	NULL
&	NULL
8	NULL
Q/hﬁoﬂ	NULL
0	NULL
\	NULL
ta	NULL
Cec	NULL
x4	NULL
e50	NULL
,	NULL
z	NULL
0	NULL
0	NULL
%	NULL
``	NULL
20	NULL
\o	NULL
Bo\	NULL
€s	NULL
h	NULL
o	NULL
nes	NULL
.	NULL

o	NULL
uo	NULL
tho	NULL
o	NULL
no	NULL
ue	NULL
anno	NULL
oe	NULL
dost	NULL
usc	NULL
i	NULL
o	NULL
Pans	NULL
bn	NULL
``	NULL
asta	NULL
otis	NULL
BP	NULL
e	NULL
4	NULL
.	NULL
``	NULL

&	NULL
$	NULL
a	NULL
a*	NULL
P	NULL
#	NULL
s	NULL
*	NULL
*a	NULL
s/	NULL
``	NULL
mal	NULL
HA	NULL
PF	NULL
,	NULL
``	NULL
tog	NULL
*	NULL
,	NULL
Aww	NULL
b	NULL
,	NULL
jour	NULL
kag	NULL
gobs	NULL
Ee	NULL
,	NULL
``	NULL
gold	NULL
ABMA	NULL
esq	NULL
oy	NULL
:	NULL
C	NULL
4¥	NULL
,	NULL
y	NULL
9	NULL
:	NULL
Ea	NULL
?	NULL

”	NULL
'	NULL
o'\	NULL
“	NULL
‘	NULL
7	NULL
:	NULL
°	NULL
Sr	NULL
a	NULL
oﬁaup	NULL
‘	NULL
”	NULL
$	NULL
an	NULL
``	NULL
ﬁr	NULL
cd	NULL
0	NULL
59°00	NULL
“	NULL
&	NULL
%	NULL
as	NULL
}	NULL
;	NULL
g	NULL
cui	NULL
‘	NULL
ko	NULL
‘	NULL
nuu	NULL
3:9	NULL
”	NULL
we	NULL
“	NULL
&	NULL
z	NULL
»	NULL
-o	NULL
a	NULL
92.9	NULL
6°	NULL
CIX	NULL
»	NULL
Ag	NULL
m	NULL
-	NULL
“	NULL
”	NULL
‘	NULL
°§	NULL
,	NULL
é	NULL
‘	NULL
uow	NULL
‘	NULL
y	NULL
Bay	NULL
``	NULL
%	NULL
3	NULL
%	NULL
aR	NULL
``	NULL
wm	NULL
``	NULL
n	NULL
L*	NULL
,	NULL
0	NULL
Co	NULL
``	NULL
ou	NULL
o	NULL
ﬁvh	NULL
‘	NULL
ﬂy	NULL
$	NULL
22	NULL
f	NULL
TZ	NULL
a*	NULL
00	NULL
$	NULL
t	NULL
``	NULL
5	NULL
%	NULL
iZ	NULL
«	NULL
.P	NULL
DHC	NULL
*	NULL
(	NULL
sg	NULL
.	NULL

c..	NULL
C	NULL
3	NULL
``	NULL
2	NULL
o	NULL
_	NULL
&	NULL
9	NULL
Af	NULL
*	NULL
4	NULL
k	NULL
526	NULL
sp	NULL
(	NULL
Pauk	NULL
a	NULL
,	NULL
a	NULL
RJC	NULL
,	NULL
=	NULL
g=	NULL
62	NULL
54	NULL
i	NULL
``	NULL
m.	NULL
2	NULL
&	NULL
'of	NULL
Cyd	NULL
$	NULL
%	NULL
.	NULL

3	NULL
<	NULL
9	NULL
ﬁfth	NULL
t	NULL
&	NULL
°°	NULL
%	NULL
se	NULL
#	NULL
»	NULL
3	NULL
,	NULL
``	NULL
,	NULL
Motos	NULL
Somol	NULL
,	NULL
C0	NULL
%	NULL
090	NULL
P	NULL
ys	NULL
*	NULL
4	NULL
&	NULL
*	NULL
a	NULL
“	NULL
;	NULL
»	NULL
Ao	NULL
L	NULL
``	NULL
,	NULL
‘	NULL
)	NULL
Q\	NULL
‘	NULL
u	NULL
{	NULL
hg	NULL
``	NULL
‘	NULL
°ft	NULL
5°5	NULL
,	NULL
t.w05	NULL
,	NULL
``	NULL
°	NULL
ap	NULL
``	NULL
“	NULL
QQ	NULL
t	NULL
>	NULL
s	NULL
egg	NULL
“	NULL
Xe	NULL
``	NULL
do	NULL
”	NULL
aA	NULL
Ps	NULL
I	NULL
o	NULL
%	NULL
a	NULL
I	NULL
bx	NULL
$	NULL
0	NULL
”	NULL
:	NULL
QQ-g	NULL
s*	NULL
/	NULL
o°°	NULL
95	NULL
,	NULL
205	NULL
7	NULL
,	NULL
%	NULL
ss	NULL
,	NULL
4	NULL
*a	NULL
°°0°§	NULL
bo	NULL
ay	NULL
.	NULL

i530	NULL
p	NULL
#	NULL
``	NULL
,	NULL
<	NULL
8	NULL
.	NULL

R	NULL
“	NULL
Zap	NULL
;	NULL
IS	NULL
Wag	NULL
A	NULL
a	NULL
»	NULL
f	NULL
'	NULL
:	NULL
’	NULL
ace	NULL
5	NULL
>	NULL
190°	NULL
:	NULL
9	NULL
0	NULL
%	NULL
,8	NULL
5	NULL
GQAf/	NULL
‘	NULL
i/	NULL
&	NULL
q	NULL
to	NULL
40	NULL
g	NULL
g8S®	NULL
os	NULL
,	NULL
_	NULL
’	NULL
L	NULL
‘	NULL
-ﬁ°6°	NULL
%	NULL
c	NULL
4	NULL
he	NULL
iRead	NULL
4	NULL
``	NULL
44	NULL
a	NULL
'	NULL
r	NULL
Aik	NULL
!	NULL

ghee	NULL
's	NULL
tho	NULL
a**	NULL
a	NULL
*	NULL
aI	NULL
*	NULL
kn	NULL
Paa	NULL
s	NULL
$	NULL
e	NULL
,	NULL
8	NULL
8	NULL
00	NULL
p	NULL
:	NULL
``	NULL
ath	NULL
im	NULL
%	NULL
~-	NULL
P	NULL
‘	NULL
qjgn	NULL
¢	NULL
&	NULL
x	NULL
$	NULL
°2c0	NULL
o	NULL
&	NULL
a	NULL
o	NULL
t	NULL
5	NULL
o	NULL
°	NULL
6	NULL
49	NULL
0p	NULL
o	NULL
A	NULL
4	NULL
©	NULL
8	NULL
.nf	NULL
ad	NULL
o	NULL
U_	NULL
&	NULL
o	NULL
k'ﬁﬁ	NULL
2	NULL
,	NULL
°	NULL
%	NULL
°	NULL
&	NULL
*	NULL
Q1	NULL
?	NULL
)	NULL

In	NULL
“	NULL
C	NULL
R	NULL
oe	NULL
,	NULL
®	NULL
``	NULL
1	NULL
a	NULL
'	NULL
s	NULL
)	NULL
mP	NULL
ood	NULL
Cp	NULL
~	NULL
39°	NULL
%	NULL
°	NULL
7	NULL
,	NULL
NMP	NULL
a	NULL
8	NULL
aK.a	NULL
(	NULL
1	NULL
9p	NULL
a	NULL
a	NULL
bz	NULL
hae	NULL
tRih	NULL
C.	NULL
'	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Enhanced	NULL
neutrophil	NULL
migration	NULL
in	NULL
response	NULL
to	NULL
culture	NULL
media	NULL
from	NULL
Rb-transformed	NULL
cells	NULL
.	NULL

Neutrophil	NULL
migration	NULL
was	NULL
evaluated	NULL
by	NULL
the	NULL
microwell	NULL
chemotaxis	NULL
chamber	NULL
assay	NULL
(	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

Photomicrographs	NULL
(	NULL
magnification	NULL
,	NULL
X40	NULL
)	NULL
show	NULL
representative	NULL
fields	NULL
of	NULL
the	NULL
migrated	NULL
neutrophils	NULL
in	NULL
response	NULL
to	NULL
(	NULL
4	NULL
)	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
100	NULL
ng/ml	NULL
recombinant	NULL
human	NULL
IL-8	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
,	NULL
(	NULL
C	NULL
)	NULL
culture	NULL
media	NULL
from	NULL
the	NULL
Rb-defective	NULL
1A4	NULL
subclone	NULL
,	NULL
or	NULL
(	NULL
D	NULL
)	NULL
culture	NULL
media	NULL
from	NULL
the	NULL
Rb-transformed	NULL
12-27	NULL
subclone	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
neutrophils	NULL
trapped	NULL
by	NULL
the	NULL
filter	NULL
.	NULL

Table	NULL
3	NULL
-	NULL
Neutrophil	NULL
migration	NULL
in	NULL
response	NULL
to	NULL
culture	NULL
media	NULL
from	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
cells	NULL
``	NULL
Experiment	NULL
1	NULL
Experiment	NULL
2	NULL
Sample	NULL
1:1	NULL
Dilution	NULL
1:3	NULL
Dilution	NULL
1:1	NULL
Dilution	NULL
1:3	NULL
Dilution	NULL
144	NULL
2	NULL
<	NULL
0	NULL
8	NULL
<	NULL
0	NULL
12-27	NULL
30	NULL
0	NULL
45	NULL
28	NULL
rIL-89	NULL
87	NULL
74	NULL
78	NULL
70	NULL
*	NULL
A	NULL
total	NULL
of	NULL
100	NULL
ng/ml	NULL
recombinant	NULL
human	NULL
IL-8	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
.	NULL

Data	NULL
were	NULL
obtained	NULL
after	NULL
subtracting	NULL
negative	NULL
control	NULL
.	NULL

®	NULL
rIL-8	NULL
,	NULL
recombinant	NULL
IL-8	NULL
.	NULL

lution	NULL
of	NULL
this	NULL
issue	NULL
awaits	NULL
a	NULL
direct	NULL
test	NULL
of	NULL
the	NULL
hypothesis	NULL
that	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
enhances	NULL
cell	NULL
growth	NULL
rates	NULL
.	NULL

Antitumor	NULL
Immunity	NULL
and	NULL
Rb	NULL
.	NULL

Baskar	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
have	NULL
found	NULL
that	NULL
tumor	NULL
cells	NULL
transfected	NULL
with	NULL
and	NULL
expressing	NULL
class	NULL
II	NULL
molecules	NULL
can	NULL
immunize	NULL
mice	NULL
against	NULL
a	NULL
subsequent	NULL
challenge	NULL
of	NULL
parental	NULL
,	NULL
class	NULL
II-negative	NULL
tumor	NULL
cells	NULL
.	NULL

Similar	NULL
conclusions	NULL
have	NULL
been	NULL
drawn	NULL
using	NULL
a	NULL
rat	NULL
model	NULL
system	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
tumor	NULL
cells	NULL
defective	NULL
for	NULL
Rb	NULL
,	NULL
which	NULL
can	NULL
not	NULL
express	NULL
HLA	NULL
class	NULL
II	NULL
after	NULL
exposure	NULL
to	NULL
IFN-y	NULL
,	NULL
may	NULL
be	NULL
less	NULL
immuno-genic	NULL
.	NULL

IL-8	NULL
secretion	NULL
now	NULL
represents	NULL
a	NULL
second	NULL
immune	NULL
function	NULL
regulated	NULL
by	NULL
Rb	NULL
.	NULL

Enhanced	NULL
neutrophil	NULL
migration	NULL
in	NULL
response	NULL
to	NULL
culture	NULL
media	NULL
from	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
is	NULL
consistent	NULL
with	NULL
this	NULL
increased	NULL
IL-8	NULL
secretion	NULL
having	NULL
a	NULL
functional	NULL
impact	NULL
on	NULL
the	NULL
neutrophils	NULL
,	NULL
although	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
there	NULL
could	NULL
be	NULL
additional	NULL
,	NULL
Rb-dependent	NULL
components	NULL
of	NULL
the	NULL
culture	NULL
media	NULL
enhancing	NULL
neutrophil	NULL
migration	NULL
.	NULL

A	NULL
role	NULL
for	NULL
IL-8	NULL
in	NULL
antitumor	NULL
immunity	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
following	NULL
:	NULL
(	NULL
a	NULL
)	NULL
recombinant	NULL
IL-8	NULL
inhibits	NULL
the	NULL
proliferation	NULL
of	NULL
some	NULL
non-small	NULL
cell	NULL
lung	NULL
carcinoma	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
anti-IL-8	NULL
antibody	NULL
eliminates	NULL
this	NULL
effect	NULL
(	NULL
38	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
Taxol	NULL
,	NULL
an	NULL
antitumor	NULL
drug	NULL
,	NULL
induces	NULL
the	NULL
secretion	NULL
of	NULL
IL-8	NULL
but	NULL
not	NULL
IL-1	NULL
or	NULL
IL-6	NULL
from	NULL
ovarian	NULL
carcinoma	NULL
cell	NULL
lines	NULL
(	NULL
39	NULL
)	NULL
;	NULL
(	NULL
c	NULL
)	NULL
differentiation-inducing	NULL
agents	NULL
,	NULL
such	NULL
as	NULL
retinoic	NULL
acid	NULL
,	NULL
calcitriol	NULL
,	NULL
and	NULL
sodium	NULL
butyrate	NULL
,	NULL
up-regulate	NULL
IL-8	NULL
expression	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
;	NULL
and	NULL
(	NULL
d	NULL
)	NULL
tumor-infiltrating	NULL
lymphocytes	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
IL-8	NULL
(	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
also	NULL
reports	NULL
contradicting	NULL
the	NULL
proposal	NULL
that	NULL
IL-8	NULL
enhances	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
t	NULL
p	NULL
el	NULL
'yum	NULL
Ravel	NULL
C	NULL
ce	NULL
yeu	NULL
wel	NULL
wl	NULL
w=	NULL
Oct-1	NULL
mp	NULL
moura	NULL
_	NULL
(	NULL
A	NULL
)	NULL
4	NULL
£	NULL
&	NULL
£	NULL
&	NULL
da	NULL
g	NULL
$	NULL
|	NULL
und	NULL
~	NULL
o	NULL
OU	NULL
Op	NULL
o	NULL
e	NULL
<	NULL
od	NULL
<	NULL
d	NULL
ves	NULL
!	NULL

w=	NULL
w=	NULL
w=	NULL
pOct-1	NULL
=p	NULL
~	NULL
(	NULL
B	NULL
)	NULL
Oct-	NULL
_	NULL
@	NULL
e	NULL
@	NULL
c-s-e-	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Hyperphosphorylation	NULL
of	NULL
Oct-1	NULL
in	NULL
the	NULL
Rb-transformed	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Western	NULL
blotting	NULL
(	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
of	NULL
Oct-1	NULL
in	NULL
the	NULL
Rb-defective	NULL
and	NULL
Rb-transformed	NULL
5637	NULL
subclones	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
from	NULL
each	NULL
5637	NULL
subclone	NULL
was	NULL
analyzed	NULL
.	NULL

B	NULL
,	NULL
hyperphosphorylation	NULL
of	NULL
Oct-1	NULL
in	NULL
12-27	NULL
cells	NULL
5637	NULL
subclones	NULL
were	NULL
metabolically	NULL
labeled	NULL
by	NULL
[	NULL
°PJorthophosphate	NULL
.	NULL

Oct-1	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Phosphorylated	NULL
Oct-1	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
top	NULL
panel	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

This	NULL
same	NULL
gel	NULL
was	NULL
transferred	NULL
and	NULL
blotted	NULL
by	NULL
anti-Oct-1	NULL
antibody	NULL
(	NULL
arrow	NULL
,	NULL
bottom	NULL
panel	NULL
!	NULL
)	NULL

.	NULL

antitumor	NULL
immunity	NULL
(	NULL
24	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Melanoma	NULL
cell	NULL
lines	NULL
with	NULL
higher	NULL
IL-8	NULL
secretion	NULL
have	NULL
a	NULL
stronger	NULL
tendency	NULL
for	NULL
metastasis	NULL
in	NULL
nude	NULL
mice	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
IL-8	NULL
to	NULL
induce	NULL
angiogenesis	NULL
in	NULL
tumors	NULL
is	NULL
regarded	NULL
as	NULL
the	NULL
contributing	NULL
factor	NULL
in	NULL
tumor	NULL
development	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
determination	NULL
the	NULL
exact	NULL
roles	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
and	NULL
IL-8	NULL
in	NULL
the	NULL
antitumor	NULL
response	NULL
requires	NULL
additional	NULL
investigation	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
Rb	NULL
can	NULL
regulate	NULL
at	NULL
least	NULL
two	NULL
tumor	NULL
cell	NULL
immune	NULL
functions	NULL
in	NULL
addition	NULL
to	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
.	NULL

The	NULL
human	NULL
bladder	NULL
carcinoma	NULL
cell	NULL
line	NULL
5637	NULL
(	NULL
ATCC	NULL
HTB-9	NULL
;	NULL
Refs	NULL
.	NULL

16	NULL
and	NULL
17	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Hyclone	NULL
}	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin-streptomycin	NULL
,	NULL
3	NULL
mm	NULL
L-glutamine	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
sodium	NULL
pyruvate	NULL
.	NULL

1A4	NULL
and	NULL
1¥1	NULL
are	NULL
Rb-defective	NULL
5637	NULL
subclones	NULL
transformed	NULL
with	NULL
the	NULL
G418-resistant	NULL
gene	NULL
.	NULL

12-27	NULL
and	NULL
10-1	NULL
are	NULL
5637	NULL
subclones	NULL
transformed	NULL
with	NULL
an	NULL
Rb	NULL
expression	NULL
vector	NULL
and	NULL
the	NULL
G418-resistant	NULL
gene	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
Refs	NULL
.	NULL

6	NULL
and	NULL
16	NULL
)	NULL
.	NULL

They	NULL
are	NULL
maintained	NULL
by	NULL
adding	NULL
200	NULL
ug/ml	NULL
Geneticin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
to	NULL
the	NULL
culture	NULL
media	NULL
used	NULL
for	NULL
culturing	NULL
the	NULL
5637	NULL
cells	NULL
.	NULL

S4-MTRb-1	NULL
is	NULL
a	NULL
Rb-transformed	NULL
subclone	NULL
of	NULL
the	NULL
human	NULL
breast	NULL
carcinoma	NULL
cell	NULL
line	NULL
$	NULL
4	NULL
(	NULL
Table	NULL
1	NULL
;	NULL
Refs	NULL
.	NULL

7	NULL
and	NULL
9	NULL
)	NULL
.	NULL

$	NULL
4	NULL
and	NULL
S4-MTRb-1	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
:	NULL
F12	NULL
(	NULL
Mediatech	NULL
)	NULL
,	NULL
10	NULL
%	NULL
calf	NULL
serum	NULL
(	NULL
Hy-clone	NULL
)	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin-streptomycin	NULL
,	NULL
3	NULL
mm	NULL
i-glutamine	NULL
,	NULL
and	NULL
50	NULL
ng/m	NULL
!	NULL

epidermal	NULL
growth	NULL
factor	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
EMSAs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
44	NULL
)	NULL
,	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cells/10-cm	NULL
dish	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
and	NULL
once	NULL
with	NULL
hypotonic	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
EGTA	NULL
,	NULL
20	NULL
mm	NULL
sodium	NULL
fluoride	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mm	NULL
phenylmethylsulfonyl	NULL
flu-oride	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
300	NULL
wl	NULL
of	NULL
hypotonic	NULL
buffer	NULL
containing	NULL
0.2	NULL
%	NULL
NP4O0	NULL
and	NULL
protease	NULL
inhibitors	NULL
(	NULL
0.5	NULL
ug/ml	NULL
!	NULL

leupeptin	NULL
,	NULL
2	NULL
ug/ml	NULL
!	NULL

aprotinin	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
antipain	NULL
;	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
separated	NULL
from	NULL
cytosolic	NULL
components	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
s	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
wl	NULL
of	NULL
high	NULL
salt	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
840	NULL
mm	NULL
sodium	NULL
Table	NULL
4	NULL
-	NULL
Quantitative	NULL
analysis	NULL
of	NULL
Oct-1	NULL
phosphorylation	NULL
POct-1	NULL
``	NULL
Oct-1	NULL
POct-1:0ct-1	NULL
Relative	NULL
ratio	NULL
144	NULL
(	NULL
24	NULL
h	NULL
)	NULL
121.8	NULL
178.8	NULL
0.6812	NULL
1.000	NULL
12-27	NULL
(	NULL
24	NULL
h	NULL
)	NULL
188.1	NULL
160.6	NULL
1.171	NULL
1.719	NULL
144	NULL
(	NULL
48	NULL
h	NULL
)	NULL
174.1	NULL
201.0	NULL
0.8662	NULL
1.271	NULL
12-27	NULL
(	NULL
48	NULL
h	NULL
)	NULL
232.9	NULL
113.1	NULL
2.059	NULL
3.023	NULL
``	NULL
POct-1	NULL
,	NULL
phosphorylated	NULL
Oct-1	NULL
.	NULL

chloride	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
EGTA	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
fluoride	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
1	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
0.5	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
the	NULL
protease	NULL
inhibitors	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
intermittent	NULL
mixing	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
tubes	NULL
were	NULL
centrifuged	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
(	NULL
4°C	NULL
)	NULL
.	NULL

The	NULL
supernatants	NULL
(	NULL
nuclear	NULL
extracts	NULL
)	NULL
were	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
for	NULL
later	NULL
use	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
BCA	NULL
protein	NULL
assay	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
for	NULL
the	NULL
EMSAs	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
,	NULL
21	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
synthesized	NULL
wild-type	NULL
and	NULL
mutant	NULL
HLA-DRA	NULL
octamer	NULL
oligonucleotides	NULL
,	NULL
with	NULL
the	NULL
octamer	NULL
element	NULL
underlined	NULL
and	NULL
the	NULL
mutated	NULL
nucleotides	NULL
in	NULL
lowercase	NULL
letters	NULL
,	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
wild-type	NULL
,	NULL
5'-AGAGTAATTGATITGCATTTTAATGG-3	NULL
'	NULL
(	NULL
sense	NULL
strand	NULL
)	NULL
and	NULL
5'-CCATTA-AAATGCAAATCAATTACT-3	NULL
'	NULL
(	NULL
antisense	NULL
strand	NULL
)	NULL
;	NULL
and	NULL
mutant	NULL
,	NULL
5'-AGAG-TAATTGecaTGgATITTAATGG-3	NULL
'	NULL
(	NULL
sense	NULL
strand	NULL
)	NULL
and	NULL
5'-CCATT-AAAATcCAtggCAATTACT-3	NULL
'	NULL
(	NULL
antisense	NULL
strand	NULL
)	NULL
.	NULL

The	NULL
HLA-DRA	NULL
Y	NULL
box	NULL
oligonucleotide	NULL
sequences	NULL
are	NULL
5'-AAATATTTTITCTGATTGGCCAAAGAG-TAAT-3	NULL
'	NULL
(	NULL
sense	NULL
strand	NULL
)	NULL
and	NULL
5'-ATTACTCTTTGGCCAATCAGAAAAAT-3	NULL
'	NULL
(	NULL
antisense	NULL
strand	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
for	NULL
the	NULL
IL-8	NULL
promoter	NULL
octamer	NULL
probes	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
wild-type	NULL
,	NULL
5'-TCATCAGT-TGCAAATCGTGG-3	NULL
'	NULL
(	NULL
sense	NULL
strand	NULL
)	NULL
and	NULL
5'-TCCACGATITGCAACT-GATG-3	NULL
'	NULL
(	NULL
antisense	NULL
-	NULL
strand	NULL
)	NULL
;	NULL
and	NULL
-	NULL
mutant	NULL
,	NULL
-	NULL
5'-TCATCtigTGCAAt-gCGTGG-3	NULL
'	NULL
(	NULL
sense	NULL
strand	NULL
)	NULL
and	NULL
5'-TCCACGcaTTGCAcaaGATG-3	NULL
'	NULL
(	NULL
antisense	NULL
strand	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
Yu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
0.025	NULL
pmol	NULL
of	NULL
[	NULL
a-°2P	NULL
]	NULL
dCTP	NULL
or	NULL
[	NULL
a-°°P	NULL
]	NULL
dATP	NULL
end-labeled	NULL
double-stranded	NULL
probe	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
in	NULL
a	NULL
20-ul	NULL
incubation	NULL
mixture	NULL
containing	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
deoxyinosinic-deoxy-cytidylic	NULL
acid	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
Boehinger	NULL
Mannheim	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
or	NULL
supershift	NULL
experiment	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
preincubated	NULL
with	NULL
a	NULL
10-fold	NULL
or	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
or	NULL
1	NULL
ul	NULL
of	NULL
monoclonal	NULL
antibody	NULL
(	NULL
anti-Oct-1	NULL
and	NULL
the	NULL
control	NULL
anti-epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
were	NULL
both	NULL
bought	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
combined	NULL
with	NULL
the	NULL
labeled	NULL
probes	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
nondenaturing	NULL
polyacylam-ide	NULL
gel	NULL
and	NULL
autographed	NULL
.	NULL

Reporter	NULL
Constructs	NULL
,	NULL
Transfections	NULL
,	NULL
and	NULL
Luciferase	NULL
Assays	NULL
.	NULL

To	NULL
generate	NULL
the	NULL
wild-type	NULL
HLA-DRA	NULL
luciferase	NULL
reporter	NULL
(	NULL
pDRAlucWT	NULL
)	NULL
,	NULL
the	NULL
-176	NULL
to	NULL
+45	NULL
fragment	NULL
of	NULL
HLA-DRA	NULL
promoter	NULL
was	NULL
excised	NULL
from	NULL
pDRA-CAT	NULL
(	NULL
19	NULL
)	NULL
and	NULL
subcloned	NULL
into	NULL
pUC18	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
then	NULL
excised	NULL
from	NULL
pUC18	NULL
using	NULL
Asp	NULL
``	NULL
'®	NULL
and	NULL
Sa/l	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
Asp	NULL
``	NULL
'®	NULL
and	NULL
Xhol	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
pGL3	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
mutant	NULL
construct	NULL
(	NULL
pDRAlucOCTmut	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
subcloning	NULL
the	NULL
same	NULL
DRA	NULL
promoter	NULL
fragment	NULL
with	NULL
four	NULL
nucleotide	NULL
substitutions	NULL
within	NULL
octamer	NULL
box	NULL
(	NULL
5'-ATTTGCAT-3	NULL
'	NULL
to	NULL
5'-ccalTG	NULL
@	NULL
gAT-3	NULL
'	NULL
)	NULL
into	NULL
the	NULL
pGL3	NULL
vector	NULL
.	NULL

Both	NULL
the	NULL
wild-type	NULL
and	NULL
octamer	NULL
mutant	NULL
DRACAT	NULL
plasmids	NULL
were	NULL
generous	NULL
gifts	NULL
of	NULL
Dr.	NULL
Laurie	NULL
Glimcher	NULL
(	NULL
Harvard	NULL
University	NULL
School	NULL
of	NULL
Public	NULL
Health	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
}	NULL
.	NULL

Both	NULL
DRA	NULL
luciferase	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
octamer-mutated	NULL
IL-8	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

For	NULL
transient	NULL
transfections	NULL
,	NULL
5637	NULL
or	NULL
12-27	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells/35-mm	NULL
dish	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
with	NULL
7.5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
performed	NULL
five	NULL
times	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
100	NULL
ng	NULL
(	NULL
DRA	NULL
promoter	NULL
reporters	NULL
)	NULL
or	NULL
1	NULL
ug	NULL
(	NULL
IL-8	NULL
promoter	NULL
reporters	NULL
)	NULL
of	NULL
DNA	NULL
was	NULL
transfected	NULL
using	NULL
a	NULL
liposome	NULL
method	NULL
(	NULL
Trans	NULL
IT-LT1	NULL
;	NULL
Mirus	NULL
Corp.	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Six	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
,	NULL
received	NULL
fresh	NULL
media	NULL
,	NULL
and	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
42	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
0.25	NULL
m	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
by	NULL
three	NULL
rounds	NULL
of	NULL
freezing	NULL
(	NULL
95	NULL
%	NULL
ethanol/dry	NULL
ice	NULL
)	NULL
and	NULL
thawing	NULL
(	NULL
37°C	NULL
)	NULL
.	NULL

The	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
commercial	NULL
re	NULL
463	NULL
Rb	NULL
Regulation	NULL
of	NULL
Oct-1	NULL
and	NULL
IL-8	NULL
agents	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Light	NULL
emissions	NULL
were	NULL
measured	NULL
by	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
(	NULL
Beckman	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
Cytoplasmic	NULL
RNA	NULL
and	NULL
Northern	NULL
Blotting	NULL
Analysis	NULL
.	NULL

Cytoplasmic	NULL
RNAs	NULL
from	NULL
the	NULL
cultured	NULL
5637	NULL
cells	NULL
and	NULL
its	NULL
subclones	NULL
were	NULL
extracted	NULL
and	NULL
stored	NULL
as	NULL
an	NULL
ethanol	NULL
precipitate	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Northern	NULL
blotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Luca	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
,	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

RNA	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
fractionated	NULL
in	NULL
a	NULL
1	NULL
%	NULL
denaturing	NULL
formaldehyde/agarose	NULL
gel	NULL
.	NULL

The	NULL
fractionated	NULL
RNA	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
filter	NULL
membrane	NULL
(	NULL
Hybond-N	NULL
;	NULL
Amersham	NULL
)	NULL
and	NULL
UV	NULL
cross-linked	NULL
(	NULL
UV-Stratalinker	NULL
1800	NULL
;	NULL
Stratagene	NULL
)	NULL
.	NULL

Prehybridization	NULL
was	NULL
performed	NULL
at	NULL
42°C	NULL
in	NULL
6	NULL
x	NULL
SSC	NULL
containing	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
100	NULL
g/m	NULL
!	NULL

salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

A	NULL
0.5-kb	NULL
EcoRI	NULL
fragment	NULL
representing	NULL
human	NULL
IL-8	NULL
cDNA	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
agarose	NULL
gel	NULL
by	NULL
using	NULL
the	NULL
Qiaquick	NULL
kit	NULL
(	NULL
Qiagen	NULL
)	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
a-°	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
using	NULL
a	NULL
nick	NULL
translation	NULL
kit	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
42°C	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
washed	NULL
twice	NULL
with	NULL
2	NULL
x	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50°C	NULL
and	NULL
then	NULL
washed	NULL
once	NULL
with	NULL
0.1	NULL
x	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
60°C	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
film	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-70°C	NULL
.	NULL

Another	NULL
set	NULL
of	NULL
RNA	NULL
samples	NULL
was	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
described	NULL
above	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
to	NULL
evaluate	NULL
the	NULL
integrity	NULL
and	NULL
concentration	NULL
of	NULL
the	NULL
ribosomal	NULL
RNAs	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
IL-8	NULL
mRNA	NULL
and	NULL
the	NULL
corresponding	NULL
28S	NULL
rRNA	NULL
bands	NULL
was	NULL
done	NULL
using	NULL
ImageQuaNT	NULL
computer	NULL
software	NULL
(	NULL
version	NULL
4.2a	NULL
,	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

ELISA	NULL
and	NULL
Neutrophil	NULL
Migration	NULL
Assay	NULL
.	NULL

Culture	NULL
media	NULL
for	NULL
5637	NULL
subclones	NULL
were	NULL
collected	NULL
at	NULL
24	NULL
h	NULL
after	NULL
plating	NULL
.	NULL

ELISA	NULL
determination	NULL
of	NULL
IL-8	NULL
concentrations	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
Cytokine	NULL
Core	NULL
Laboratory	NULL
at	NULL
University	NULL
of	NULL
Maryland	NULL
at	NULL
Baltimore	NULL
(	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Culture	NULL
media	NULL
from	NULL
triplate	NULL
samples	NULL
of	NULL
each	NULL
subclone	NULL
were	NULL
analyzed	NULL
.	NULL

Neutrophil	NULL
migration	NULL
assay	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
48-well	NULL
microchemotaxis	NULL
chamber	NULL
(	NULL
Neuro	NULL
Probe	NULL
,	NULL
Inc.	NULL
,	NULL
Cabin	NULL
John	NULL
,	NULL
MD	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
proto-col.	NULL
Neutrophils	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
normal	NULL
adult	NULL
volunteers	NULL
(	NULL
South	NULL
West	NULL
Florida	NULL
Blood	NULL
Bank	NULL
,	NULL
Tampa	NULL
,	NULL
FL	NULL
;	NULL
Ref	NULL
.	NULL

48	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
Blotting	NULL
.	NULL

5637	NULL
subclones	NULL
(	NULL
50-80	NULL
%	NULL
confluent	NULL
monolayer	NULL
in	NULL
10-cm	NULL
dish	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
3	NULL
m	NULL
!	NULL

of	NULL
labeling	NULL
media	NULL
[	NULL
phosphate	NULL
free-DMEM	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
dialyzed	NULL
FCS	NULL
and	NULL
0.1	NULL
mCi/ml	NULL
!	NULL

inorganic	NULL
phosphate	NULL
(	NULL
NEXO54	NULL
;	NULL
DuPont	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
]	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
labeled	NULL
cells	NULL
as	NULL
described	NULL
above	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
Oct-1	NULL
,	NULL
5	NULL
ul	NULL
of	NULL
mouse	NULL
anti-human	NULL
Oct-1	NULL
antibody	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
)	NULL
and	NULL
10	NULL
ul	NULL
recombinant	NULL
protein	NULL
G	NULL
agarose	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
were	NULL
added	NULL
to	NULL
250	NULL
ul	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
at	NULL
2,500	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
at	NULL
4°C	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
using	NULL
a	NULL
10	NULL
%	NULL
gel	NULL
,	NULL
the	NULL
wet	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
Kodak	NULL
film	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
°P-labeled	NULL
Oct-1	NULL
,	NULL
and	NULL
the	NULL
band	NULL
intensities	NULL
were	NULL
quantified	NULL
using	NULL
ImmageQuaNT	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

To	NULL
immunoblot	NULL
Oct-1	NULL
,	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Du-Pont	NULL
New	NULL
England	NULL
Nuclear	NULL
Research	NULL
Products	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
192	NULL
mm	NULL
glycine	NULL
,	NULL
and	NULL
20	NULL
%	NULL
methanol	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
blocked	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
PBS	NULL
containing	NULL
5	NULL
%	NULL
milk	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Antibody	NULL
blotting	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
membrane	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
5	NULL
%	NULL
milk	NULL
containing	NULL
10	NULL
wl	NULL
of	NULL
anti-Oct-1	NULL
(	NULL
1:1,000	NULL
dilution	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
for	NULL
5	NULL
min	NULL
each	NULL
time	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
2.5	NULL
pl	NULL
(	NULL
1:12,500	NULL
dilution	NULL
)	NULL
of	NULL
horseradish	NULL
peroxidase-labeled	NULL
rabbit	NULL
antimouse	NULL
antibody	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
membrane	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
reaction	NULL
was	NULL
detected	NULL
using	NULL
enhanced	NULL
chemiluminescence	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Chen	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Riley	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
W-H	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
as	NULL
a	NULL
fundamental	NULL
mediator	NULL
of	NULL
growth	NULL
and	NULL
differentiation	NULL
signals	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Eukaryot	NULL
.	NULL

Gene	NULL
Expr	NULL
.	NULL

,	NULL
5	NULL
:	NULL
79-95	NULL
,	NULL
1995	NULL
.	NULL

2	NULL
.	NULL

Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
,	NULL
81	NULL
:	NULL
323-330	NULL
,	NULL
1995	NULL
.	NULL

3	NULL
.	NULL

Goodrich	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
W-H.	NULL
Molecular	NULL
characterization	NULL
of	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1155	NULL
:	NULL
43-61	NULL
,	NULL
1993	NULL
.	NULL

4	NULL
.	NULL

Huang	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Yee	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Shew	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Chen	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Bookstein	NULL
,	NULL
R.	NULL
,	NULL
Friedmann	NULL
,	NULL
T.	NULL
,	NULL
Lee	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
W-H.	NULL
Suppression	NULL
of	NULL
the	NULL
neoplastic	NULL
phenotype	NULL
by	NULL
replacement	NULL
of	NULL
the	NULL
RB	NULL
gene	NULL
in	NULL
human	NULL
cancer	NULL
cells	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
242	NULL
:	NULL
1563-1566	NULL
,	NULL
1988	NULL
.	NULL

5	NULL
.	NULL

Sumegi	NULL
,	NULL
J.	NULL
,	NULL
Uzvolgyi	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Klein	NULL
,	NULL
G.	NULL
Expression	NULL
of	NULL
the	NULL
RB	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
MuLC-LTR	NULL
suppresses	NULL
tumorigenicity	NULL
of	NULL
WERI-Rb-27	NULL
retinoblastoma	NULL
cell	NULL
in	NULL
immunodefective	NULL
mice	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

,	NULL
1	NULL
:	NULL
247-250	NULL
,	NULL
1990	NULL
.	NULL

6	NULL
.	NULL

Zhou	NULL
,	NULL
Y.	NULL
,	NULL
Li	NULL
,	NULL
J.	NULL
,	NULL
Xu	NULL
,	NULL
K.	NULL
,	NULL
Hu	NULL
,	NULL
S-X	NULL
.	NULL

,	NULL
Benedict	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
and	NULL
Xu	NULL
,	NULL
H-J	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
retinoblastoma	NULL
gene-mediated	NULL
cell	NULL
growth	NULL
and	NULL
tumor	NULL
suppression	NULL
in	NULL
human	NULL
cancer	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
:	NULL
4165-4169	NULL
,	NULL
1994	NULL
.	NULL

7	NULL
.	NULL

Muncaster	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Cohen	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Phillips	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Gallie	NULL
,	NULL
B.	NULL
L.	NULL
Failure	NULL
of	NULL
RB1	NULL
to	NULL
reverse	NULL
the	NULL
malignant	NULL
phenotype	NULL
of	NULL
human	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
52	NULL
:	NULL
654-661	NULL
,	NULL
1992	NULL
.	NULL

8	NULL
.	NULL

Santhanam	NULL
,	NULL
U.	NULL
,	NULL
Ray	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sehgal	NULL
,	NULL
P.	NULL
B.	NULL
Repression	NULL
of	NULL
the	NULL
interleukin	NULL
6	NULL
gene	NULL
promoter	NULL
by	NULL
p53	NULL
and	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
prod-uct	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
7605-7609	NULL
,	NULL
1991	NULL
.	NULL

9	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
Ussery	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Muncaster	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Gallie	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
and	NULL
Blanck	NULL
,	NULL
G.	NULL
Evidence	NULL
for	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
RB	NULL
)	NULL
dependent	NULL
and	NULL
independent	NULL
IFN-y	NULL
responses	NULL
:	NULL
RB	NULL
coordinately	NULL
rescues	NULL
IFN-y	NULL
induction	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
in	NULL
noninducible	NULL
breast	NULL
carcinoma	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
:	NULL
1015-1019	NULL
,	NULL
1994	NULL
.	NULL

10	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
Boss	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Hu	NULL
,	NULL
S-X	NULL
.	NULL

,	NULL
Xu	NULL
,	NULL
H-J	NULL
.	NULL

,	NULL
and	NULL
Blanck	NULL
,	NULL
G.	NULL
Apoptosis-independent	NULL
retinoblastoma	NULL
protein	NULL
rescue	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
messenger	NULL
RNA	NULL
IFN-y	NULL
inducibility	NULL
in	NULL
non-small	NULL
cell	NULL
lung	NULL
carcinoma	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
156	NULL
:	NULL
2495-2502	NULL
,	NULL
1996	NULL
.	NULL

11	NULL
.	NULL

Sehgal	NULL
,	NULL
P.	NULL
B.	NULL
Interleukin	NULL
6	NULL
in	NULL
infection	NULL
and	NULL
cancer	NULL
.	NULL

Proc	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
195	NULL
:	NULL
183-191	NULL
,	NULL
1990	NULL
.	NULL

12	NULL
.	NULL

Urashima	NULL
,	NULL
M.	NULL
,	NULL
Ogata	NULL
,	NULL
A.	NULL
,	NULL
Chauhan	NULL
,	NULL
D.	NULL
,	NULL
Vidriales	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Teoh	NULL
,	NULL
G.	NULL
,	NULL
Hoshi	NULL
,	NULL
Y.	NULL
,	NULL
Schlossman	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
K.	NULL
C.	NULL
Interleukin-6	NULL
promotes	NULL
multiple	NULL
myeloma	NULL
cell	NULL
growth	NULL
via	NULL
phosphorylation	NULL
of	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
:	NULL
2219-2227	NULL
,	NULL
1996	NULL
.	NULL

13	NULL
.	NULL

Zhu	NULL
,	NULL
Y.	NULL
M.	NULL
,	NULL
Bradbury	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Keith	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
and	NULL
Russell	NULL
,	NULL
N.	NULL
Absence	NULL
of	NULL
retinoblastoma	NULL
protein	NULL
expression	NULL
results	NULL
in	NULL
autocrine	NULL
production	NULL
of	NULL
interleukin-6	NULL
and	NULL
promotes	NULL
the	NULL
autonomous	NULL
growth	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
blast	NULL
cells	NULL
.	NULL

Leukemia	NULL
(	NULL
Baltimore	NULL
)	NULL
,	NULL
8	NULL
:	NULL
1982-1988	NULL
,	NULL
1994	NULL
.	NULL

14	NULL
.	NULL

Kern	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Klarnet	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Jensen	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Greenberg	NULL
,	NULL
P.	NULL
D.	NULL
Requirement	NULL
for	NULL
recognition	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
and	NULL
processed	NULL
tumor	NULL
antigen	NULL
for	NULL
optimal	NULL
generation	NULL
of	NULL
syngeneic	NULL
tumor-specific	NULL
class	NULL
|-re-stricted	NULL
CTL	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
136	NULL
:	NULL
4303-4310	NULL
,	NULL
1986	NULL
.	NULL

15	NULL
.	NULL

Topalian	NULL
,	NULL
S.	NULL
L.	NULL
MHC	NULL
class	NULL
II	NULL
restricted	NULL
tumor	NULL
antigens	NULL
and	NULL
the	NULL
role	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
in	NULL
cancer	NULL
immunotherapy	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
741-745	NULL
,	NULL
1994	NULL
.	NULL

16	NULL
.	NULL

Berry	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Lu	NULL
,	NULL
Y.	NULL
,	NULL
Schmidt	NULL
,	NULL
B.	NULL
,	NULL
Fallon	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
O'Connell	NULL
,	NULL
C.	NULL
,	NULL
Hu	NULL
,	NULL
S-X	NULL
.	NULL

,	NULL
Xu	NULL
,	NULL
H-J	NULL
.	NULL

,	NULL
and	NULL
Blanck	NULL
,	NULL
G.	NULL
Retinoblastoma	NULL
protein	NULL
inhibits	NULL
IFN-y	NULL
induced	NULL
apoptosis	NULL
.	NULL

Oncogene	NULL
,	NULL
12	NULL
:	NULL
1809-1819	NULL
,	NULL
1996	NULL
.	NULL

17	NULL
.	NULL

Osborne	NULL
,	NULL
A.	NULL
,	NULL
Tschickardt	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Blanck	NULL
,	NULL
G.	NULL
Retinoblastoma	NULL
protein	NULL
expression	NULL
facilitates	NULL
chromatin	NULL
remodeling	NULL
at	NULL
the	NULL
HLA-DRA	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
25	NULL
:	NULL
5095-5102	NULL
,	NULL
1997	NULL
.	NULL

18	NULL
.	NULL

Ting	NULL
,	NULL
J.	NULL
P-Y	NULL
.	NULL

Current	NULL
concepts	NULL
in	NULL
DRA	NULL
gene	NULL
regulation	NULL
.	NULL

Immunol	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
12	NULL
:	NULL
65-77	NULL
,	NULL
1993	NULL
.	NULL

19	NULL
.	NULL

Reimold	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
Transforming	NULL
growth	NULL
factor	NULL
B1	NULL
repression	NULL
of	NULL
the	NULL
HLA-DRa	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
conserved	NULL
proximal	NULL
promoter	NULL
elements	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
157	NULL
:	NULL
4173-4182	NULL
,	NULL
1993	NULL
.	NULL

20	NULL
.	NULL

Sherman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Basta	NULL
,	NULL
P.	NULL
V.	NULL
,	NULL
Heguy	NULL
,	NULL
A.	NULL
,	NULL
Wloch	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Ting	NULL
,	NULL
J.	NULL
P-Y	NULL
.	NULL

The	NULL
octamer	NULL
motif	NULL
is	NULL
a	NULL
B-lymphocyte-specific	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
HLA-DRa	NULL
gene	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
6739-6743	NULL
,	NULL
1989	NULL
.	NULL

21	NULL
.	NULL

Wu	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Lai	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Huang	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Wen	NULL
,	NULL
X.	NULL
Oct-1	NULL
and	NULL
CCAAT/	NULL
enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
bind	NULL
to	NULL
overlapping	NULL
elements	NULL
within	NULL
the	NULL
interleukin-8	NULL
promoter	NULL
:	NULL
the	NULL
role	NULL
of	NULL
Oct-1	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
:	NULL
2396-2403	NULL
,	NULL
1997	NULL
.	NULL

22	NULL
.	NULL

Grenfell	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Latchman	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
S.	NULL
B.	NULL
OCT-1	NULL
and	NULL
Oct-2	NULL
DNA-binding	NULL
site	NULL
specificity	NULL
is	NULL
regulated	NULL
in	NULL
vitro	NULL
by	NULL
different	NULL
kinases	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
375	NULL
:	NULL
889-893	NULL
,	NULL
1996	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
23	NULL
.	NULL

Matsushima	NULL
,	NULL
K.	NULL
,	NULL
Morishita	NULL
,	NULL
K.	NULL
,	NULL
Yoshimura	NULL
,	NULL
T.	NULL
,	NULL
Lavu	NULL
,	NULL
S.	NULL
,	NULL
Kobayashi	NULL
,	NULL
Y.	NULL
,	NULL
Lew	NULL
,	NULL
W.	NULL
,	NULL
Appella	NULL
,	NULL
E.	NULL
,	NULL
Kung	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
Leonard	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
Oppenheim	NULL
,	NULL
J.	NULL
J.	NULL
Molecular	NULL
cloning	NULL
of	NULL
a	NULL
human	NULL
monocyte-derived	NULL
neutrophil	NULL
chemotactic	NULL
factor	NULL
(	NULL
MDNCF	NULL
)	NULL
and	NULL
induction	NULL
of	NULL
MDNCF	NULL
mRNA	NULL
by	NULL
interleukin	NULL
1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
167	NULL
:	NULL
1883-1893	NULL
,	NULL
1988	NULL
.	NULL

24	NULL
.	NULL

Luca	NULL
,	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
S.	NULL
,	NULL
Gershenwald	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Singh	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Reich	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bar-Eli	NULL
,	NULL
M.	NULL
Expression	NULL
of	NULL
interleukin-8	NULL
by	NULL
human	NULL
melanoma	NULL
cells	NULL
up-regulates	NULL
MMP-2	NULL
activity	NULL
and	NULL
increases	NULL
tumor	NULL
growth	NULL
and	NULL
metastasis	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
151	NULL
:	NULL
1105-1113	NULL
,	NULL
1997	NULL
.	NULL

25	NULL
.	NULL

Segil	NULL
,	NULL
N.	NULL
,	NULL
Roberts	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Heintz	NULL
,	NULL
N.	NULL
Mitotic	NULL
phosphorylation	NULL
of	NULL
the	NULL
Oct-1	NULL
homeodomain	NULL
and	NULL
regulation	NULL
of	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
254	NULL
:	NULL
1814-1816	NULL
,	NULL
1991	NULL
.	NULL

26	NULL
.	NULL

Murphy	NULL
,	NULL
S.	NULL
Differential	NULL
in	NULL
vivo	NULL
activation	NULL
of	NULL
the	NULL
class	NULL
II	NULL
and	NULL
class	NULL
III	NULL
snRNA	NULL
genes	NULL
by	NULL
the	NULL
POU-specific	NULL
domain	NULL
of	NULL
Oct-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
25	NULL
:	NULL
2068-2076	NULL
,	NULL
1997	NULL
.	NULL

27	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
and	NULL
Van	NULL
der	NULL
Vliet	NULL
,	NULL
P.	NULL
C.	NULL
POU	NULL
domain	NULL
transcription	NULL
factors	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1173	NULL
:	NULL
1-21	NULL
,	NULL
1993	NULL
.	NULL

28	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
Immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
9	NULL
:	NULL
373-398	NULL
,	NULL
1991	NULL
.	NULL

29	NULL
.	NULL

Lopez-Rodriguez	NULL
,	NULL
C.	NULL
,	NULL
Zubiaur	NULL
,	NULL
M.	NULL
,	NULL
Sancho	NULL
,	NULL
J.	NULL
,	NULL
Concha	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Corbi	NULL
,	NULL
A.	NULL
L.	NULL
An	NULL
octamer	NULL
element	NULL
functions	NULL
as	NULL
a	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
differ-entiation-responsive	NULL
CD11c	NULL
integrin	NULL
gene	NULL
promoter	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
158	NULL
:	NULL
5833-5840	NULL
,	NULL
1997	NULL
.	NULL

30	NULL
.	NULL

Thevenin	NULL
,	NULL
C.	NULL
,	NULL
Lucas	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Kozlow	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
Kehrl	NULL
,	NULL
J.	NULL
H.	NULL
Cell	NULL
type-and	NULL
stage-specific	NULL
expression	NULL
of	NULL
the	NULL
CD20/B1	NULL
antigen	NULL
correlates	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
diverged	NULL
octamer	NULL
DNA	NULL
motif	NULL
present	NULL
in	NULL
its	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
:	NULL
5949-5956	NULL
,	NULL
1993	NULL
.	NULL

31	NULL
.	NULL

Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
Klein-HeBling	NULL
,	NULL
S.	NULL
,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Chuvpilo	NULL
,	NULL
S.	NULL
,	NULL
Escher	NULL
,	NULL
C.	NULL
,	NULL
Brabletz	NULL
,	NULL
T.	NULL
,	NULL
Hentsch	NULL
,	NULL
B.	NULL
,	NULL
Schwarzenbach	NULL
,	NULL
H.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
Octamer	NULL
factors	NULL
exert	NULL
a	NULL
dual	NULL
effect	NULL
on	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
153	NULL
:	NULL
5572-5585	NULL
,	NULL
1994	NULL
.	NULL

32	NULL
.	NULL

Matthias	NULL
,	NULL
P.	NULL
Lymphoid-specific	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
conserved	NULL
octamer	NULL
site	NULL
:	NULL
who	NULL
is	NULL
doing	NULL
what	NULL
?	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
155-163	NULL
,	NULL
1998	NULL
.	NULL

33	NULL
.	NULL

Roberts	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
Segil	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Heintz	NULL
,	NULL
N.	NULL
Differential	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Oct-1	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
253	NULL
:	NULL
1022-1026	NULL
,	NULL
1991	NULL
.	NULL

34	NULL
.	NULL

Harris	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Bohni	NULL
,	NULL
R.	NULL
,	NULL
Schneiderman	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Ramamurthy	NULL
,	NULL
L.	NULL
,	NULL
Schumperli	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Marzluff	NULL
,	NULL
W.	NULL
F.	NULL
Regulation	NULL
of	NULL
histone	NULL
mRNA	NULL
in	NULL
the	NULL
unperturbed	NULL
cell	NULL
cycle	NULL
:	NULL
evidence	NULL
suggesting	NULL
control	NULL
at	NULL
two	NULL
posttranscrip-tional	NULL
steps	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
:	NULL
2416-2424	NULL
,	NULL
1991	NULL
.	NULL

35	NULL
.	NULL

Baskar	NULL
,	NULL
S.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
,	NULL
Nabavi	NULL
,	NULL
N.	NULL
,	NULL
Jones	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
and	NULL
Ostrand-Rosenberg	NULL
,	NULL
S.	NULL
Major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II+B7-1+	NULL
tumor	NULL
cells	NULL
are	NULL
potent	NULL
vaccines	NULL
for	NULL
stimulating	NULL
tumor	NULL
rejection	NULL
in	NULL
tumor-bearing	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
:	NULL
619-629	NULL
,	NULL
1995	NULL
.	NULL

36	NULL
.	NULL

Baskar	NULL
,	NULL
S.	NULL
,	NULL
Clements	NULL
,	NULL
V.	NULL
,	NULL
Glimcher	NULL
,	NULL
L.	NULL
,	NULL
Nabavi	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Ostrand-Rosenberg	NULL
,	NULL
S.	NULL
Rejection	NULL
of	NULL
MHC	NULL
class	NULL
II-transfected	NULL
tumor	NULL
cells	NULL
requires	NULL
induction	NULL
of	NULL
tumor-encoded	NULL
B7-1	NULL
and/or	NULL
B7-2	NULL
costumulatory	NULL
molecules	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
156	NULL
:	NULL
3821-3827	NULL
,	NULL
1996	NULL
.	NULL

37	NULL
.	NULL

Frey	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Cestari	NULL
,	NULL
S.	NULL
Killing	NULL
of	NULL
rat	NULL
adenocarcinoma	NULL
13762	NULL
in	NULL
situ	NULL
by	NULL
adoptive	NULL
transfer	NULL
of	NULL
CD4+	NULL
anti-tumor	NULL
T	NULL
cells	NULL
requires	NULL
tumor	NULL
expression	NULL
of	NULL
cell	NULL
surface	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
178	NULL
:	NULL
79-90	NULL
,	NULL
1997	NULL
.	NULL

38	NULL
.	NULL

Wang	NULL
,	NULL
J.	NULL
,	NULL
Huang	NULL
,	NULL
M.	NULL
,	NULL
Lee	NULL
,	NULL
P.	NULL
,	NULL
Komanduri	NULL
,	NULL
K.	NULL
,	NULL
Sharma	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Dubinett	NULL
,	NULL
S.	NULL
M.	NULL
Interleukin-8	NULL
inhibits	NULL
non-small	NULL
cell	NULL
lung	NULL
cancer	NULL
pro-liferation	NULL
:	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
regulation	NULL
of	NULL
tumor	NULL
growth	NULL
by	NULL
autocrine	NULL
and	NULL
paracrine	NULL
pathways	NULL
.	NULL

J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

,	NULL
16	NULL
:	NULL
53-60	NULL
,	NULL
1996	NULL
.	NULL

39	NULL
.	NULL

Lee	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Schuerer-Maly	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Lofquist	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
van	NULL
Haaften-Day	NULL
,	NULL
C.	NULL
,	NULL
Ting	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
White	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Martin	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
and	NULL
Haskill	NULL
,	NULL
J.	NULL
S.	NULL
Taxol-dependent	NULL
transcriptional	NULL
activation	NULL
of	NULL
IL-8	NULL
expression	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
human	NULL
ovarian	NULL
cancer	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
56	NULL
:	NULL
1303-1308	NULL
,	NULL
1996	NULL
.	NULL

40	NULL
.	NULL

Atkins	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
and	NULL
Troen	NULL
,	NULL
B.	NULL
R.	NULL
Comparative	NULL
responsiveness	NULL
of	NULL
HL-60	NULL
,	NULL
HL-60R	NULL
,	NULL
and	NULL
HL-6OR+	NULL
(	NULL
LRARSN	NULL
)	NULL
cells	NULL
to	NULL
retinoic	NULL
acid	NULL
,	NULL
calcitriol	NULL
,	NULL
9	NULL
cis-retinoic	NULL
acid	NULL
,	NULL
and	NULL
sodium	NULL
butyrate	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
:	NULL
2475-2480	NULL
,	NULL
1995	NULL
.	NULL

41	NULL
.	NULL

Facchetti	NULL
,	NULL
P.	NULL
,	NULL
Prigione	NULL
,	NULL
I.	NULL
,	NULL
Ghiotto	NULL
,	NULL
F.	NULL
,	NULL
Tasso	NULL
,	NULL
P.	NULL
,	NULL
Garaventa	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Pistoia	NULL
,	NULL
V.	NULL
Functional	NULL
and	NULL
molecular	NULL
characterization	NULL
of	NULL
tumor-infiltrating	NULL
lymphocytes	NULL
and	NULL
clones	NULL
thereof	NULL
from	NULL
a	NULL
major-histocompatibility-com-plex-negative	NULL
human	NULL
tumor	NULL
:	NULL
neuroblastoma	NULL
.	NULL

Cancer	NULL
Immunol	NULL
.	NULL

Immu-nother	NULL
.	NULL

,	NULL
42	NULL
:	NULL
170-178	NULL
,	NULL
1996	NULL
.	NULL

42	NULL
.	NULL

Kitadali	NULL
,	NULL
Y.	NULL
,	NULL
Haruma	NULL
,	NULL
K.	NULL
,	NULL
Sumi	NULL
,	NULL
K.	NULL
,	NULL
Yamamoto	NULL
,	NULL
S.	NULL
,	NULL
Ue	NULL
,	NULL
T.	NULL
,	NULL
Yokozaki	NULL
,	NULL
H.	NULL
,	NULL
Yasui	NULL
,	NULL
W.	NULL
,	NULL
Ohmoto	NULL
,	NULL
Y.	NULL
,	NULL
Kajiyama	NULL
,	NULL
G.	NULL
,	NULL
Fidler	NULL
,	NULL
I.	NULL
J.	NULL
,	NULL
and	NULL
Tahara	NULL
,	NULL
E.	NULL
Expression	NULL
of	NULL
interleukin-8	NULL
correlates	NULL
with	NULL
vascularity	NULL
in	NULL
human	NULL
gastric	NULL
carcino-mas	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
152	NULL
:	NULL
93-100	NULL
,	NULL
1998	NULL
.	NULL

43	NULL
.	NULL

Singh	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Gutman	NULL
,	NULL
M.	NULL
,	NULL
Radinsky	NULL
,	NULL
R.	NULL
,	NULL
Bucana	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
Fidler	NULL
,	NULL
I.	NULL
J	NULL
.	NULL

Expression	NULL
of	NULL
interleukin	NULL
8	NULL
correlates	NULL
with	NULL
the	NULL
metastatic	NULL
potential	NULL
of	NULL
human	NULL
melanoma	NULL
cells	NULL
in	NULL
nude	NULL
mice	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
54	NULL
:	NULL
3242-3247	NULL
,	NULL
1994	NULL
.	NULL

44	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
6419	NULL
,	NULL
1989	NULL
.	NULL

45	NULL
.	NULL

Abdulkadir	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Krishna	NULL
,	NULL
S.	NULL
,	NULL
Thanos	NULL
,	NULL
D.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Ono	NULL
,	NULL
S.	NULL
J.	NULL
Functional	NULL
roles	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Oct-2A	NULL
and	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
I/Y	NULL
in	NULL
HLA-DRA	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
182	NULL
:	NULL
487-500	NULL
,	NULL
1995	NULL
.	NULL

46	NULL
.	NULL

Yu	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Meyer	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Campbell	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Carter-Su	NULL
,	NULL
C.	NULL
,	NULL
Schwartz	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Jove	NULL
,	NULL
R.	NULL
Enhanced	NULL
DNA-binding	NULL
activity	NULL
of	NULL
a	NULL
Stat3-related	NULL
protein	NULL
in	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
Src	NULL
oncoprotein	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
269	NULL
:	NULL
81-83	NULL
,	NULL
1995	NULL
.	NULL

47	NULL
.	NULL

Blanck	NULL
,	NULL
G.	NULL
,	NULL
Lok	NULL
,	NULL
M.	NULL
,	NULL
Kok	NULL
,	NULL
K.	NULL
,	NULL
Downie	NULL
,	NULL
E.	NULL
,	NULL
Korn	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
y-Interferon	NULL
induction	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
mRNAs	NULL
in	NULL
dermal	NULL
fibroblasts	NULL
studied	NULL
by	NULL
RNAse	NULL
protection	NULL
analysis	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
29	NULL
:	NULL
150-156	NULL
,	NULL
1990	NULL
.	NULL

48	NULL
.	NULL

Wei	NULL
,	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Blanchard	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
and	NULL
Djeu	NULL
,	NULL
J.	NULL
Y	NULL
.	NULL

Induction	NULL
of	NULL
IL-8	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
polymorphonuclear	NULL
neutrophils	NULL
by	NULL
recombinant	NULL
IL-2	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
152	NULL
;	NULL
3630-3636	NULL
,	NULL
1994	NULL
.	NULL

